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Porcine reproductive and respiratory syndrome virus (PRRSV) was inoculated into 
multiple PRRSV-vaccinated and nonvaccinated late term pregnant sows for investigation of 
the effect of varied exposure dose on vaccine-induced protection, the effect of PRRSV 
infection on progesterone levels and ovary, and the relative suitability of virus isolation, 
immunohistochemistry, fetal serology, and reverse transcription polymerase chain reaction 
for the detection of transplacental fetal infection. In phase 1, dead and virus infected fetuses 
were identified at necropsy on postinoculation day 21 in 4 of 4, 3 of 3, and 3 of 4 litters from 
nonvaccinated sows and 0 of 4, I of 2, and 1 of 4 litters from PRRSV-vaccinated sows 
inoculated with 102, 104, or I0b CCID50 of PRRSV strain NADC-8 respectively. The rate of 
infection was significantly different (P<.001) between the vaccinated and nonvaccinated 10" 
CCID50 groups. Litter infection rates were lower in the higher dose vaccinated groups but not 
significantly different from nonvaccinates. No difference in the rate of infection of fetuses 
within transplacentally infected litters was identified regardless of dose or vaccination status. 
In phase 2, plasma progesterone levels were not different from controls regardless of 
vaccination status or dose group, no ovarian lesions were detected on light microscopy, and 
no PRRSV was detected in ovarian tissues by immunohistochemistry or by in situ 
hybridization. In phase 3, virus isolation, immunohistochemical staining, and fetal serology 
identified PRRSV infection in 48.6, 23.4, and 14.9% of 107 fetuses respectively, and 
identified at least one infected fetus in 10, 10, and 5 of 10 litters respectively. In-utero death 
with autolysis reduced the test efficacy of all three methods. Fetal thoracic fluid and tissues 
proved equally suitable for rtPCR detection of PRRSV. Pooling of fetal tissues or fluids from 
VI-positive animals with comparable material from negative controls had no detrimental 
V 
effect on rtPCR results when evaluated at dilutions of 1:1, 1:2, 1:4, and 1:8. The results of 
rtPCR testing were positive in 100, 94.4, and 83.3% of VI-positive specimens allowed to 
autolyze at 4, 21 or 37°C respectively. Compared to the other testing modalities, rtPCR 
appeared to be impacted the least by autolysis. 
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CHAPTER 1. GENERAL INTRODUCTION 
Among the most frustrating of events for the livestock producer and his veterinary 
advisor is that of abortion. The establishment of a breeding herd represents a major outlay in 
economic and temporal terms. Animals must be fed, housed, and grown until breeding age. 
Breeding stock must be selected and matched for traits compatible with the intended use of 
the offspring, whether for further reproduction or terminal market use. The selected animals 
must be mated and maintained throughout gestation, often in dedicated facilities. When, after 
this extended preparation, the result, rather than healthy infants, is an agglomeration of fetal 
parts and membranes in various stages of putrefaction, the producer's angst is 
understandable. 
The growth of intensively managed confinement production of swine has 
accomplished much in terms of efficiency, while at the same time allowing swine herds to be 
more prone to certain disease processes. Because confinement swine are raised with little or 
no contact with other herds, it is entirely possible that a given herd can become naïve to 
specific infectious disease agents. In addition, narrowed genetic focus of the herd may allow 
the resistance of a specific bloodline to become less than optimum to a given disease-
producing agent. When under these conditions an infectious agent is introduced the severity 
of the resulting outbreak can be devastating. Severe outbreaks of abortion diseases can be 
nearly fatal to the continued economic existence of a livestock operation. Even in cases of 
endemic conditions a low, continuous rate of abortion may be an unacceptable economic 
burden. 
Unfortunately, although an accurate and timely diagnosis of infectious abortion 
initiators is highly desirable to guide efficient management response, under practical 
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conditions diagnosis of the cause of abortion is frequently unsuccessful. The nature of 
abortion is in many ways responsible. The diagnostic specimens practically available in 
abortion cases consist of products of abortion (fetuses and fetal membranes), maternal serum, 
and, to a lesser extent, maternal tissues. Abortion is often a symptom of or sequel to a 
primary disease process of the dam that may leave behind little or nothing in the way of 
lesions in fetal tissues. Evidence of the prerequisite infection of the dam may be gathered by 
measuring the serologic response to the agent. However, as exposure to and replication of the 
infectious agents often precedes abortion by weeks, the maternal titer to that agent may be at 
its maximum point at the time of abortion. In such cases, paired serum samples do not reflect 
true acute and convalescent states, and will not provide conclusive evidence of recent, active 
infection. Especially in herds that have been vaccinated or in which a specific condition has 
become endemic, interpretation of serologic titers is problematic. Examination of maternal 
tissues usually requires sacrifice of the dam- hardly an economic benefit- and in many cases 
the disease process is in the resolving phase and its lesions no longer dramatic or specific. 
In swine, the most prevalent infectious cause of abortion in today's production 
systems is porcine reproductive and respiratory syndrome virus (PRRSV). Porcine 
reproductive and respiratory syndrome (PRRS) was first described in 1987 and was initially 
termed "mystery disease of swine". Although PRRS has been the subject of extensive 
research during the last decade, the exact mechanism of abortion has yet to be elucidated. 
Exposure of susceptible sows to PRRSV has readily caused abortion, yet diagnostic 
procedures typically attempted in cases of abortion using fetal tissues have proven to be poor 
to dismal in their ability to provide evidence of infection, particularly in field cases. In most 
cases, there are no definitive lesions in the fetus. Virus isolation procedures have proven of 
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little worth on tissues of aborted, dead fetuses due to the labile nature of the agent. 
Immunohistochemical staining has been nearly equally disappointing. Diagnosis, therefor, 
depends all too often on serological examination of the breeding herd. This is, however, 
attendant with the pitfalls previously mentioned. In those instances where a naive herd is 
exposed, undergoes an abortion storm, and seroconverts, a presumptive diagnosis is often 
established with some degree of confidence. In field situations, however, these cases are a 
distinct minority. Many PRRS abortions occur as a result of irregular levels of immunity in 
individuals or subpopulations within endemically infected herds, and the interpretation of 
serological data is oftentimes judgmental. 
The decision on how to respond to an abortion outbreak is an important one. In 
today's large swine herds- many of which manage in excess of 10,000 breeding animals- this 
is a decision involving an annual expenditure of 525,000 or more for vaccines alone, 
irrespective of the labor costs and the effects of vaccination stress on the herd. And, if the 
incorrect agent is implicated, the losses due to abortion may continue alongside the vaccine 
expense. 
As a result, it is highly desirable that our understanding of PRRS pathogenesis be 
expanded, and that improved diagnostic procedures for PRRSV-related reproductive disease 
be developed. Accordingly, the research elaborated in this dissertation was designed to shed 
light on both pathogenesis and diagnosis of PRRSV-associated reproductive disease. 
From a pathogenesis standpoint, our research focused on two principle aspects. First, 
although severe outbreaks of PRRS have frequently been experienced in naïve herds, 
previously exposed and immune herds, many of which practice regular vaccination, also have 
endured reproductive losses. Whether any agent is capable of causing disease is a function of 
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exposure dose and virulence of the agent as opposed to the defenses of the host, of which 
vaccine-induced immunity may be a major component. This immune protection may be 
circumvented by strain variation between vaccine and challenge viruses, or overcome by 
relatively massive exposure doses. We hypothesized that a large exposure dose of field 
virulent virus may be able to overwhelm immunity and result in acute disease. To investigate 
this premise, multiple vaccinated and nonvaccinated swine were exposed to titered doses of 
virulent virus. This trial is reported in detail in Chapter 3. 
Secondly, because PRRSV frequently leaves no lesion in uterine or fetal tissues, we 
hypothesized that PRRSV may induce abortion via a direct or an indirect effect on the corpus 
luteum, a structure required for maintenance of pregnancy in swine. To quantify such an 
effect, serial plasma samples were obtained subsequent to PRRSV exposure and the 
progesterone levels determined. The presence of PRRSV antigen in ovarian tissue was 
explored using immunohistochemistry and in situ hybridization on formalin fixed tissue. 
These results are presented in detail in Chapter 4. 
Of primary concern to the diagnostic pathologist is a thorough understanding of the 
most effective and efficient procedures for obtaining a definitive diagnosis in cases of 
PRRSV-associated reproductive disease. Because, as already mentioned, PRRS leaves no 
lesions in aborted fetuses, and the agent is nearly always inactivated by postmortem 
degeneration in utero and cannot be reliably isolated, a more dependable method of 
identifying PRRSV infection in transplacental^ infected fetuses is not only desirable, but 
imperative. Reverse transcription polymerase chain reaction (rtPCR) testing has been 
demonstrated to identify PRRSV genetic material in a variety of tissues and fluids. This 
technique has promise in abortion diagnosis because it does not depend on viable virus, but 
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can detect genetic material in inactivated or incomplete virus particles. Fetal serology has not 
been commonly utilized for PRRSV diagnosis although it has potential application. 
Techniques of immunohistochemistry and virus isolation have been used successfully for 
demonstration of PRRSV. This research compared the ability of virus isolation, fetal 
serology, immunohistochemical staining, and rtPCR testing on fetal tissues. In addition, 
rtPCR results on tissues exposed to varying degrees of postmortem degeneration were 
compared. 
Dissertation Organization 
This dissertation is made up of a general introduction, literature review, and three 
papers prepared as individual publications, followed by a statement of general conclusions. 
Each paper is co-authored by Dr. M. J. Yaeger, major professor and principle investigator for 
this dissertation research, and others as listed below. These papers are: 
• Chapter 3 : Effect of porcine reproductive and respiratory syndrome virus 
(PRRSV) exposure dose on fetal infection in vaccinated and nonvaccinated swine, 
a paper published in Swine Health and Production. Kelly M. Lager, DVM, Ph.D., 
is co-author, and provided material assistance in conception and virus isolation 
procedures. 
• Chapter 4: Effect of porcine reproductive and respiratory syndrome virus 
infection on the ovary and progesterone levels in third trimester pregnant sows, a 
paper submitted to Theriogenology. Steven P. Ford, Ph.D., collaborated on the 
progesterone studies and is co-author. 
• Chapter 5: A comparison of virus isolation, immunohistochemistry, fetal serology, 
and reverse transcription polymerase chain reaction for the identification of 
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porcine reproductive and respiratory syndrome virus transplacental infection in 
the fetus, a paper submitted to The Journal of Veterinary Diagnostic Investigation 
Co-authors are Dr. Lager, Jane Christopher-Hennings, DVM, Ph.D., and Kyong-
Jin Yoon, DVM, Ph.D., who were involved in conception and execution of 
virologie and serologic studies. 
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CHAPTER 2. LITERATURE REVIEW 
Historical Background 
In 1987, an outbreak of disease associated with reproductive failure and respiratory 
disease in swine occurred in the United States.161 The common presentation consisted of 
sudden onset of abortion, infertility, birth of stillborn, weak, or nonviable pigs, and neonatal 
respiratory distress frequently complicated by secondary bacterial infections.99-131,224,401 As 
many as 50% of litters could be affected, and losses were severe. Although many secondary 
or concurrent conditions were suspected or proven, the primary cause remained undefined, 
and the syndrome came to be referred to as mystery swine disease. The syndrome spread to 
Canada by 1987, Germany and the Netherlands by 1990, and France, Belgium, Britain, and 
Spain by 1991, and has subsequently spread worldwide.15-34-4S-99• l7°-l95-242-305• -47-401 
The syndrome was referred to as disease 89, pig plague 89, SMEDI-like syndrome, swine 
reproductive failure syndrome, porcine epidemic abortion and respiratory syndrome 
(PEARS), swine infertility and respiratory syndrome (SIRS), and blue ear disease. 125-261 
The causative agent was isolated in Denmark in 1991 and designated the Lelystad virus 
(LV).366-368-369 Shortly thereafter the first US strains were identified.25-6S-23S-387 Koch's 
postulates were fulfilled with LV in 1991.331-368 In 1992, it was agreed that the name porcine 
respiratory and reproductive syndrome (PRRS) would be universally applied, and its 
causative agent referred to as PRRS virus (PRRSV). 125 
Porcine reproductive and respiratory syndrome virus is now considered endemic in 
swine producing countries.2-3-401 Serologic profiling demonstrated the presence of PRRS 
antibody in 0% of 1425 serum samples collected in Iowa in 1980, 3.8% of 356 collected in 
1985, and 47.6% of 658 collected in 1988 (1989 figures were higher but represented very 
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limited numbers of animals and herds).401 The 1988 figures represent a herd prevalence of 
63%. 401 A 1990 serologic survey of 87 farms in 18 states revealed an infection prevalence of 
82.7% of tested herds;17 a similar survey in 1992 demonstrated antibody in samples from 
56.3% of primarily Midwestern herds.54 Because the samples analyzed in the 1990 and 1992 
studies were routine submissions and information on age and/or parity was not available, 
differences in herd prevalence may reflect differences in the sampling technique. The 
National Animal Health Monitoring System Swine '95 study performed by the United States 
Department of Agriculture on 286 herds in 16 states identified PRRSV antibody in samples 
from 68.5% of herds overall; when considering only herds in which no PRRS vaccine was 
used, the prevalence was 59.4%.12 
A retrospective study demonstrated IgG antibody against PRRSV by enzyme-linked 
immunosorbent assay (ELISA) and indirect fluorescent antibody test (IFA) in approximately 
4, 18, 20, and 20% of serum samples from sows each representing a different farm in 
Ontario, Canada collected in 1979, 1980, 1981, and 1982 respectively; approximately 50 
samples collected in each year were examined.42 This is the earliest reported evidence of 
PRRSV infection. The lapse of time before clinical disease was described was not explained, 
but the researcher suggested the possibility of a lesser virulent virus in circulation prior to 
1987.42 
Porcine Reproductive and Respiratory Syndrome Virus 
Porcine reproductive and respiratory syndrome virus is classed in the order 
Nodovirales, family Arteriviridea, genus Arterivirus along with equine arteritis virus (EAV), 
lactate dehydrogenase elevating virus of mice (LDV), and simian hemorrhagic fever virus 
(SHFV). 45-231.232.26S. 279,342 This classification was made official by the International 
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Committee on Virus Taxonomy in 1996.45 Inclusion in Nodovirales is based on the following 
characteristics: 1) a genome composed of linear nonsegmented single stranded positive-
sense RNA; 2) genomic RNA acting as the mRNA for the translation of a 5' sequence 
encoding the replicase (RNA polymerase) gene; 3) a genome consisting of a 5' leader 
sequence followed by polymerase genes, and structural protein genes at the 3' end; and 4) a 
nested set of 3' subgenomic mRNAs of which only the unique 5' regions are translated. 45 
Other characteristics of the arteriviruses include presence of a virion envelope (membrane), 
an internal membrane protein which spans the membrane at least 3 times, a 3'polyadenylated 
tail, and the encoding of two open reading frames (ORFs) in gene I, with frameshifting 
between translation of ORFs la and lb.45 Among the arteriviruses are common 
characteristics of preferential growth in macrophages, induction of persistent infections, 
method of gene expression, and organization of genome.45-79-233-268 
Both the Lelystad strain and American strains of PRRSV have been extensively 
characterized.25-69-74-76-233-235 Characterization of the ATCC VR-2332 strain of PRRSV 
demonstrated an average diameter of 62 nm with a 25-30 nm core, and that the virus 
replicates exclusively in cytoplasm.25 Porcine reproductive and respiratory syndrome virus 
is an enveloped, single stranded, positive-sense RNA virus with a genome of 15.1 kilobases. 
Eight ORFs have been identified. Open reading frames la and lb represent approximately 
80% of the PRRSV genome, encode for RNA polymerase, and are similar to the highly 
conserved polymerase encoding regions found in EAV, LDV, Berne torovirus, and 
coronavirus genomes.233-351 Two papain-like cysteine proteases are also encoded by regions 
of ORF la.9' Open reading frames 2 through 7 putatively encode for structural proteins, 
specifically a nucleocapsid protein (ORF 7), four glycoproteins (ORFs 2 through 5), and an 
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unglycosylated membrane protein (ORF 6).233-351 The number of nested subgenomic 
mRNAs (sgmRNA) varies among strains, with most strains being composed of 6 
sgmRNAs,210 while some strains, such as ISU79, possess a seventh sgmRNA designated 3-
1.214,248 %he genetic sequences of LV indicate a close relationship with LDV and EAV, and 
show a more distant relationship with coronaviruses and toroviruses.233 
Comparison of the genome of several European and US strains of PRRSV with LV 
demonstrates significant variability in their genetic sequences.204-233-248 The comparison of 
amino acid sequences of ORFs 2 through 7 demonstrated 63, 60, 70, 55, 79, and 64% 
homology respectively between LV and VR23 3 2.233-243-244 In common with other single-
stranded RNA viruses, genetic changes and antigenic diversity are frequent among PRRSV 
isolates.96-,22'l57-15s-19,1205-213-248-267-292-322,367- 386,393 A region of glycoprotein (GP) 5, 
the protein product of ORF 5, has been shown to be most highly associated with these 
genomic changes and the development of quasispecies.292 Genomic analysis and 
monoclonal antibodies prepared against US and European isolates reflect this variation, and 
identify variability throughout the genome.8-I0-44- ,0'-1l5-2I°-243-248- 25°-292-367-393 This 
variability may be a source of error in identification of virus or antibody in field cases if not 
taken into consideration.'7-367 393 An epitope coded by ORF 7, designated EpORF7-A, has 
been shown to be highly conserved among US and European strains of PRRSV and has been 
suggested as a target for diagnostic tests.385 Serologic studies have also demonstrated the 
different reactivities of the US and Lelystad-type isolates.303-3,3 
Strains of PRRSV also vary in their pathogenicity as demonstrated by their ability to 
cause reproductive and respiratory disease and to infect macrophages in vitro. I37-138- '4'-2'9-
226,291 
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Pathogenesis 
Inactivity and establishment of infection 
Porcine reproductive and respiratory syndrome is highly infectious; a limited study 
demonstrated that 3 of 3 pigs became infected when exposed to 101 TCDD^oof virus by 
intranasal or intramuscular routes.392 Another study demonstrated that 10 or fewer virions 
were adequate to induce infection of young pigs by the intramuscular and intranasal routes; 
these researchers speculated that one virion may be adequate for infection.392 
Following oronasal exposure, PRRSV rapidly spreads, being demonstrated in 
bronchiolar and nasal turbinate epithelial cells, pulmonary vascular endothelium, tonsillar 
macrophages, and pulmonary intravascular, interstitial, and alveolar macrophages at 12 hours 
post inoculation (PI), suggesting that the port of entry for PRRSV is tonsil, turbinate, and 
pulmonary epithelium and their resident macrophages.46-I05-2S5-286 Following initial 
exposure PRRSV replicates in macrophages, primarily within lymphatic organs (lymph 
nodes and tonsil)27, with development of viremia by 12 to 24 hours postexposure.285 Virus 
concentrations peak in serum about 4 days post inoculation (DPI).127 Activated alveolar 
macrophages have been demonstrated to be more supportive of viral replication than 
monocytes.20-103 Virus replication in lung tissue is reduced between 9 and 20 DPI.172 This 
may be the effect of a shift in the alveolar cell population away from differentiated 
macrophages and toward monocytes as infection progresses.172 Monocytes have been shown 
to increase 2 to 5 fold between 9 and 52 DPI, while differentiated macrophages decreased in 
numbers.172 
Following development of viremia, the virus affects lymphoid tissues in general and 
can be demonstrated in macrophages in various organs.27-46-285 In situ hybridization (ISH) 
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for PRRSV RNA on tissues of experimentally infected gnotobiotic pigs sampled 21 DPI 
demonstrated PRRSV genetic material primarily in macrophages in lymph nodes, nasal 
turbinate, stomach, small intestine, spiral colon, heart, aorta, brain, kidney, thymus, spleen, 
and tonsil.190 In six-week-old pigs, ISH labeled PRRSV genetic material in lymphoid tissue, 
Payer's patches, type II pneumocytes, alveolar macrophages, and kidney between 4 and 42 
DPI.324 Virus has been isolated from nasal turbinates, tonsil, lung, serum, plasma, buffy coat, 
spleen, and lymph nodes.352 In the lung, virus has been demonstrated in amounts as high as 
10s'9 TCID50 per gram of tissue.352 A comparison of pulmonary alveolar macrophages 
(PAMs) from 4-month-old and 4-week-old pigs demonstrated more resistance to viral 
replication in cells from the older pigs.340 A significant reduction in alveolar macrophages is 
a principle effect of PRRSV.301 Based on that effect and the capacity for replication of the 
virus in these cells in vitro, alveolar macrophages appear to be a primary target of the 
virus.98-,05'283'301 Viremia typically persists 7 to 21 days, but virus has been isolated from 
serum as late as 63 DPI.251259 359 
Cellular-level effects 
Virus particles bind to PAMs and gain entry into the cell by a process of receptor-
mediated endocytosis.104-246-247 The receptor is present in variable numbers on macrophages 
but exceeds 104 per cell.246 Blocking of macrophages by polyclonal or monoclonal anti-PAM 
antibodies inhibits infection by PRRSV through interference with the receptor.103 The 
cellular tropism of PRRSV, as with many other viral pathogens, is associated with such 
receptors.103-104-168 Nonsusceptible cell lines can be infected with PRRSV if treated with 
polyethylene glycol to allow fusion of the cell membrane and viral envelope168 or by 
transaction with genomic PRRSV RNA.230 
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The virions are transported in clathrin-coated vesicles into the cytoplasm where 
release of the virus particles takes place in a pH-dependent process and replication 
follows.169-246'247 This process of receptor-mediated endocytosis in clathrin-coated vesicles 
and subsequent pH-dependent activation is a common cellular pathway and not specific to 
PRRSV.49 Nucleocapsids formed in the cytosol bud into the endoplasmic reticulum.320 The 
maximum release of virus from cultured cells has been shown to occur between 10 and 20 
hours postinfection.229 Infection of cell cultures and hemagglutination can be inhibited by the 
addition of heparin suggesting that a heparin-like molecule serves as the cell receptor.154-155 
Hemagglutination which can be inhibited by heparin has been demonstrated in mouse 
erythrocytes exposed to PRRSV, but was not demonstrated with cattle, sheep, goat, horse, 
swine, guinea pig, mongolian gerbil, goose and chicken erythrocytes.153-154 
Porcine alveolar macrophages have been shown to be reduced in their ability to 
phagocytize and kill Candida albicans, Hemophilus parasuis and Staphylococcus aureus 
when infected with PRRSV.50-310 This is possibly due to inhibition of the superoxide radical 
lytic mechanism, which has been shown to be depressed at least during the first 12 hours 
PI.50-310 Similar effects on pulmonary intravascular macrophages (PIMs) have been 
demonstrated.339-340 Infection of PAMs with PRRSV results in induced expression of 
specific gene sequences; one such region encodes an ubiquitin-specific protease, suggesting 
that PRRSV has a protein metabolism regulation effect on infected cells.396 In PAMs, 
infection with PRRSV strongly reduces the expression of tumor necrosis factor alpha (TNF-
a) mRNA, and reduces the production of hydrogen peroxide and interleukin 1 alpha (IL-la) 
in the initial stages of infection; after 24 to 36 hours values rebounded.50-197 Tumor necrosis 
factor alpha has been shown to decrease the ability of PRRSV to replicate in PAMs.198 
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Porcine reproductive and respiratory syndrome virus decreases the ability of PAMs 
and PIMs to phagocytize copper particles.337 This loss of phagocytic ability may indicate a 
mechanism through which septicemias, such as that of Streptococcus suis infection, may be 
exacerbated. 
Porcine reproductive and respiratory syndrome virus has been demonstrated to inhibit 
the production of interferon-alpha (IFN-a) in PAMs in vitro, both alone and when 
coinfecting with transmissible gastroenteritis (TGE) virus, a known inducer of IFN-a.4 
Interferon-alpha levels induced by infection with PRRSV or PRRSV plus swine influenza 
virus (SIV) were slightly lower than those induced by SIV alone.353 Pretreatment of PAMs 
with IFN-a resulted in significant reductions in PRRSV yields in vitro, and a similar 
reduction in PRRSV titers in lung was demonstrated in pigs previously infected with porcine 
respiratory coronavirus (PRCV), a potent inducer of IFN-a.41 Infection with PRRSV did not 
however significantly reduce IFN-a production stimulated by PRCV.41 In infected pigs the 
T-cell mediated IFN-y response was very low and very poor during the first 9-11 weeks 
PL209 
The 25-kDa membrane protein encoded by ORF 5 has been demonstrated to induce 
apoptosis in vitro in monkey COS-1 cells.321 In vivo studies have also demonstrated 
apoptotic changes in macrophages in multiple tissues, and suggest that the increased 
populations of necrotic macrophages observed in PRRSV infected lungs may be the result of 
apoptosis due to a bystander effect rather than necrosis due to direct viral effects.308-325-326 
Apoptosis has been demonstrated in germinal epithelial cells of the testicle, and may be 
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responsible for reproductive changes in the male.325 Similar studies have not been done in 
females. 
The production of an RNA helicase identified in multiple porcine tissues has been 
demonstrated to be induced by PRRSV.397 
Clinical Presentations 
Reproductive disease 
The clinical signs of PRRS are variable, although acute outbreaks, particularly those 
involving specific virulent strains, may cause sow mortality.67'222 In naïve herds, breeding 
stock can display pyrexia, anorexia, dyspnea, agalactia, and lethargy.3-"•125-401 Cyanosis of 
the ears, vulva, and skin has been reported and gives rise to the term "blue ear" (more 
frequently used in European literature).1 '•263 Respiratory signs in otherwise healthy adults 
are mild. Reproductive disease is typically characterized by late term abortions, stillbirths, 
and premature farrowings, often occurring around day 110 of gestation.99-401 Since 1996, 
strains of more virulent PRRSV, often referred to as "atypical" or "acute" PRRSV, have 
induced disease in earlier pregnancy which resulted in abortion in which fetuses are typically 
virus negative, and the abortion appears to be a result of systemic disease rather than any 
direct affect on the fetus.215 Infertility is characterized by repeat breeding, late return to 
estrus, and persistent anestrus. "•401 
Affected litters are frequently composed of a mixture of mummified, stillborn, weak, 
and apparently normal pigs, and significant variation between litters occurs. "•l25-263-401 
Within infected litters not all pigs are infected, and not all infected pigs contain viable virus 
due to autolytic change.348 Virus can be isolated from weakborn and less often from stillborn 
fetuses, but rarely from autolysed fetuses, and fluorescent antibody tests on autolyzed fetus 
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tissues have been equally unrewarding.395 Virus was isolated from approximately 2/3 of live-
bom or stillborn pigs, but was isolated from no autolyzed fetuses in one experimental trial.56 
Weakbom pigs frequently fail to survive to weaning, and many die within the first few 
days.263 Preweaning mortality has in some cases approached 80%.263 Pigs from litters 
exposed to PRRSV during late gestation may be persistently infected and provide a 
continuing source of virus.24-26-378 This is more fully discussed under epidemiology. 
Microscopic lesions in maternal tissues in many field cases are nonexistent.56-283 
Lymphohistiocytic perivasculitis and metritis have been described in the maternal placenta 
and endometrium, and microseparations were observed in the epithelial placental interface on 
electron microscopic examination.174-318 Ultrastructural examination has demonstrated virus 
particles on the surface of maternal placental blood vessel endothelial cells, between uterine 
epithelial cells, and on fetal placental epithelial cells.318 In abortion due to EAV, a related 
arterivirus, the agent causes separation of the fetal and maternal placentas and damages 
uterine epithelium.66 Mononuclear metritis and arteritis has also been demonstrated in EAV 
infections.150-360 
The majority of field cases have no demonstrable lesions in the aborted fetuses;56-57-
68 however, lesions have been described under experimental conditions. Hemorrhage may be 
observed in umbilical cords, varying from segmental to diffuse in distribution, due to focal 
necrotizing and hemorrhagic umbilical arteritis.174 Lymphoplasmacytic foci in cardiac 
muscle, occasionally associated with loss of myocytes, and perivascular lymphoplasmacytic 
infiltrates in cardiac muscle, brain, and kidney have been described.287 Occasionally loss of 
cardiac myofibrils was severe and accompanied by fibrous replacement.287 These reports 
notwithstanding, fetal lesions in field cases are rare. 
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The mechanisms of abortion and/or fetal death are not well defined. Lymphocytic 
perivascular infiltrates observed in the uterine tissues suggest that an inflammatory process 
may be responsible for abortion.174 Umbilical arteritis may result in anoxia in fetuses, 
although the segmental distribution of these lesions may interfere with detection on 
histologic examination.174 Comparison of various field strains and the vaccine strain (VR-
2332) demonstrate that all will cross the placental barrier; however, there are significant 
differences in the ability of individual strains to cause fetal death and weakbom pigs.226-260 
Porcine reproductive and respiratory syndrome virus has been shown to most efficiently 
cross the placental barrier at about 85 to 90 days of gestation, although virus will replicate in 
fetuses at earlier ages when infected by intrauterine inoculation.55-56-175-216 Inoculation of 
sows with virus at 45 to 50 days gestation resulted in viremia and leukopenia in the sow, but 
no fetuses were affected or viremic on days 7, 14, or 21 PI, indicating that no fetal infection 
had occurred, and no abortions were observed.55 Sows in this trial which were allowed to go 
to term delivered 25 normal pigs and 3 mummified fetuses; virus was isolated from 2 pigs 
from one litter.55 In another study a Danish strain of PRRSV produced viremia in fetuses 
and fetal death when sows were intranasally exposed at 70 and 85 but not at 45 days of 
gestation.167 In one study, no effect on conception was observed when challenge was given 
at breeding, but virus was isolated from pigs at 20 DPI.278 Another study of sows infected at 
days 7, 14, and 21 days of gestation did not demonstrate abortions, although 2 of 6 litters in 
the 14 day group had transplacental^ infected fetuses.277 One litter had multiple dead fetuses 
with no detectable virus.277 
Both field strains of PRRSV and the vaccine strain VR-2332 have been shown to 
cross the placental barrier and congenially infect pigs when the dam is exposed in late 
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gestation (day 90).216-220 While the adverse affects of the field strains were more 
pronounced, and overt disease was not detected with vaccine strains, lymph node lesions and 
antibody titers in fetuses indicated fetal infection and immune response, and suggest that 
exposure to vaccine virus during pregnancy may be unadvisable, particularly when other 
infectious agents may affect the newborn pigs.220 
Following an acute outbreak, PRRSV induced reproductive disease wanes as herd 
immunity builds. Typically the clinical disease process can persist 3 to 6 months depending 
on herd exposure and management factors.6-283 Reoccurrence of the reproductive syndrome 
has been linked to genetic changes producing new strains of virus within a herd178, 
nonimmune subpopulations in the breeding herd, 2-83-401 and by introduction of new strains 
of virus from outside sources.317-376 Outbreaks associated with novel virulent strains are 
occasionally severe, and have been referred to as "super", "acute", or "atypical" PRRS.67-1l3-
219 These initial reports of high death loss in sows associated with "atypical" PRRS 
outbreaks were not confirmed by later epidemiological studies. (J. J. Zimmerman, personal 
communication) 
Diagnosis of the reproductive syndrome 
Mummified and stillborn pigs are frequently submitted for diagnostic attempts in 
abortion diseases, and have proven of little value.348 Weakbom pigs can be utilized for virus 
isolation if they have been infected in utero, but virus is rarely isolated from aborted dead 
pigs.56-179-33'•348 The most suitable specimens for diagnostic submission in reproductive 
outbreaks are presuckled weak-bom pig serum or tissues for virus isolation.179 Isolation of 
virus from the serum of aborting sows is rarely effective.179 Lesions in aborting sows are 
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limited but immunohistochemical (IHC) staining has detected PRRSV in macrophages in 
uterine tissues, lung, tonsil, and lymph nodes. 
Herd-based serology is frequently attempted to confirm a diagnosis of PRRS 
following abortion. Evaluation of paired serum samples to demonstrate the typical increase in 
titer between acute and convalescent samples can be employed if an "acute" sample can be 
obtained.349 However, if sows are exposed to PRRSV and abort some 3 weeks later, titers 
may already be nearing a peak, which can be reached as early as 4 weeks PI.394 In such a 
case the results will be equivocal. Exposure to strains of "atypical" PRRSV can result in 
abortion as soon as 5 days postexposure, in which case no titer will be present, assuming the 
sow to be previously seronegative.215 In such cases, paired samples will be rewarding while 
individual samples can be misleading. Demonstration of variable titers within a breeding 
herd suggests concurrent existence of immune and susceptible subpopulations, a condition 
which predisposes to circulation of virus and periodic reproductive disease outbreaks.2- S3.40i 
High titers in affected individuals may also be suggestive. Because of the high prevalence of 
PRRSV in modern swine herds, however, an individual sow titer cannot be interpreted to 
confirm recent infection. Vaccine-induced ELISA titers have been variable, and repeatedly 
vaccinated sows have been shown to have lower titers than those vaccinated fewer times.94 
These titers can vary from about 0.7 to nearly 2.0, and can be difficult to distinguish from 
natural exposure titers. 
Examination of fetal fluids by serology to demonstrate antibody, and by reverse 
transcription polymerase chain reaction (rtPCR) to detect the presence of genetic material, 
has not been adequately explored and is a focus of this research. Examination of serum from 
presuckled weakbom pigs has demonstrated that an immune response can occur in utero.217 
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Antibody detection in fetal serum or thoracic fluid has been attempted in abortion-related 
diseases such as toxoplasmosis,13-106- 24°-241-297 Chlamydia psittaci infection,296 
neosporosis,16-381 leptospirosis,32- "2-164 Cache valley virus infection,63- 72-I08-109 border 
disease,164 bluetongue,164 porcine parvovirus,IS5,252,311 and bovine virus diarrhea.164 Bovine 
adenovirus 3 and coronavirus antibodies have also been demonstrated in fetal fluids.236 Of 
these, toxoplasmosis, chlamydia, Cache valley virus, and neospora have had the best degree 
of practical success, while the others have been marginally applicable. Autolysis is 
mentioned as a factor that can adversely affect the success of fetal serology.240 Porcine 
fetuses were shown to develop antibody to infectious bovine rhinotracheitis when infected in 
utero.151 
Respiratory disease 
Clinical signs in growing pigs infected with PPRSV are inappetance, lethargy, and 
pyrexia.99 Neonatal pigs may show signs of severe dyspnea ("thumping"), mouth breathing, 
and lateral recumbency.99 Periocular edema has been reported beginning about 5 DPI in one-
week old pigs and persisting as long as 15 days.145-284 Sneezing is frequently observed in 
young pigs.284 In many experimental studies involving pigs from one week of age, few 
clinical signs are observed, and recovery to apparent normalcy occurs in about a week.125-352 
In field cases, however, where secondary invaders may be present or suboptimal husbandry 
practiced, significant increases in pre-and postweaning mortality are experienced.262-263•401 
Respiratory disease may become endemic and is often accompanied by secondary or 
concurrent infections in the nursery and grower phases involving such viral agents as SIV 
and PRCV, and bacterial agents including Haemophilus parasuis, Streptococcus suis. 
Salmonella cholerasuis, Actinobacillus pleuropneumoniae, Pasteurella multocida, and 
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Mycoplasma hyopneumoniae." Piglets viremic at birth have been shown to be significantly 
more susceptible to bacterial infections ( specifically S. suis ), had significantly higher death 
loss, and had lower leukocyte counts than control pigs.208 Increased susceptibility to 
septicemias may be due to a decreased ability of PIMs to phagocytize and destroy bacteria, as 
has been demonstrated with H. parasuis and Staphylococcus aureus.3I°-340 An in vitro study 
suggests that the reduction in phagocytosis by PAMs in vivo may also be the effect of 
simply decreasing the number of effective phagocytes.257 In this study, viable macrophages 
had normal phagocytic abilities.257 The inhibition of bacteriocidal activity has been attributed 
to a decrease in the production of reactive oxygen species, specifically superoxide radical.310-
340 
Whether coinfections are secondary to acute PRRS or predispose to exacerbation or 
initiation of PRRS has been the subject of much interest. Although clinical experiences 
suggest immunosuppression or synergism with other infectious agents, attempts to define 
specific interactions have been equivocal.43-70-93-10°-12°-237-273-293-299- 35°-352 PRRSV has 
been reported not to exacerbate Mycoplasma hyopneumoniae infections;165-350 however, in 
another study some increase in severity in M. hyopneumoniae related lesions was observed in 
the early stages of infection (10 DPI) in pigs coinfected with PRRSV and M. 
hyopneumoniae.334 In field studies, PRRSV seroconversion occurred significantly prior to 
seroconversion to M. hyopneumoniae, suggesting little connection between acute PRRS and 
mycoplasmosis.130 Coinfection with M. hyopneumoniae has been shown to increase the 
severity and duration of PRRSV associated lesions, even when the mycoplasmal infection 
was minimal.333 Inoculation of pigs with PRRSV followed by inoculation with a virulent 
strain of Streptococcus suis demonstrated significant enhancement of clinical disease 
compared to pigs given either pathogen alone.120,336 Infection with S. suis was also more 
severe and death loss higher following vaccination with modified-live PRRSV vaccine.133-
336 Studies demonstrated some increase in shedding of Salmonella cholerasuis from pigs 
coinfected with Salmonella cholerasuis and PRRS and increased severity of disease as 
compared to Salmonella cholerasuis alone.374 Infection of 3 to 4 -week-old pigs with 
PRRSV followed 5 days later by Pasteurella multocida demonstrated significantly less 
pneumonic change compared to pigs coinfected with pseudorabies virus and P. multocida,43 
In a field case, pigs infected with PRRSV developed systemic infection with enterotoxigenic 
E. coli, while pigs without detectable PRRSV infection showed no clinical disease, but were 
shown to be harbor the same E. coli species in their intestinal tracts.245 Pigs simultaneously 
infected with PRRSV and Haemophilus parasuis had no different tropism for either agent 
than pigs infected with the agents individually.299 No enhanced effect was demonstrated 
when pigs were infected with PRRSV followed two weeks later by TGE virus.370 Pigs 
infected with PRRSV and subsequently infected with PRCV or SIV developed more severe 
clinical disease.355 This may have been due more to the additive simultaneous damage to 
respiratory components by multiple agents than to any direct synergism.355 Another study 
was unable to demonstrate increased severity of respiratory disease when SIV followed 
PRRSV infection by 7 days, and demonstrated only mild increases in severity of 
Actinobacillus pleuropneumoniae-'mduced lesions when simultaneously infected with 
PRRSV.273 Coinfection of pigs with PRRSV and classical swine fever (CSF) (hog cholera) 
virus resulted in slightly increased severity of CSF, but the investigators concluded that the 
difference would not have been significant in a field outbreak.93 Death loss and clinical 
disease were both significantly increased when PRRSV and porcine circovirus type 2 (PCV2) 
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were simultaneously administered as compared to PRRSV alone.140 Infection of pigs with 
PRRSV did not reduce the safety but did reduce but not eliminate the efficacy of attenuated 
Erysipelothrix rhusiopathiae vaccine in 6 week old pigs; although the authors raise the 
question of immunosuppression, the stress of a simultaneous infection would have been 
adequate to inhibit optimal response to vaccination and could have occurred in conjunction 
with any of numerous other infectious agents.290-293 Simultaneous infection with multiple 
plaque variants of PRRSV has been demonstrated in neonates.258 
Clinical respiratory disease appears to be the result of damage to the respiratory 
epithelium and monocytic inflammatory cells, primarily alveolar macrophages, and these 
cells are the primary site of replication.134-285-324 In the lung, immunohistochemical staining 
demonstrates virus in sloughed pneumocytes, alveolar macrophages, and bronchiolar 
epithelium.285Immunohistochemical staining most consistently demonstrates viral antigen in 
alveolar macrophages and histiocytic cells of the alveolar septa.73 Infected cells can also be 
demonstrated in spleen, tonsil, thymus, and lymph node.141 Ultrastructural lung changes are 
described as degeneration of alveolar macrophages and pneumocytes with vacuolization of 
the endoplasmic reticulum.272 The only ultrastructural change noted in alveolar 
macrophages infected in vitro at a multiplicity of infection of 1 was an increased number of 
lysosomes.298 
Isolates of PRRSV vary in pathogenicity but display similar tissue tropisms. 137- 138-
141 For example, North American isolate VR2385 has been demonstrated to cause 
significantly more severe respiratory disease than LV or VR2431, although the tissue 
distributions were similar when examined by immunohistochemical staining and in situ 
hybridization.136-I37-141 A recent study has also demonstrated an increased severity in lung 
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lesions in Hampshire pigs when compared to Meishan and Duroc pigs, while Meishan pigs 
had significantly more severe myocardial lesions.139 This suggests that genetic susceptibility 
may be important, and will set the stage for further research in this area. 
Gross lesions 
The lesions that typify PRRS are most definitive in the lung. Lesions vary from little 
noticeable change to diffuse tan consolidation and failure to collapse.283 Lesions associated 
with secondary bacterial invaders frequently mask or overshadow PRRSV lesions.283 Lymph 
nodes are frequently enlarged and edematous, and occasionally are polycystic.283-288 
Periocular edema is occasionally observed, and less frequently mild subcutaneous dependent 
edema is noted.283 
Microscopic lesions 
Microscopic lesions in growing pigs are typical, but not pathognomonic. The 
principle lesion is interstitial pneumonia characterized by thickening of the alveolar walls 
with macrophages, lymphocytes, and lesser numbers of neutrophils and plasma cells.272-283-
286 Alveolar spaces frequently contain neutrophils, macrophages, and necrotic cellular debris 
from damaged type 1 pneumocytes. Type 2 pneumocyte proliferation follows. Syncytial cells 
have also been reported,286 although some workers have suggested these to be related to 
concurrent porcine circovirus type 2 (PCV-2) infection."1 Lung lesions are evident within 3 
DPI and persist at least 21 days.286 Perivascular mononuclear cuffs are frequently observed 
in brain, spinal cord, lung, cardiac muscle, liver, and kidney, and arteritis characterized by 
fibrinoid necrosis and lymphoplasmacytic infiltration has been described in kidney, lung, and 
brain.71-73-284 In lymph nodes germinal center hypertrophy and hyperplasia, lymphocyte 
degeneration, cystic degeneration, and formation of polykaryocytes (Warthin-Finkeldey 
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cells) has been described.286-288 Myocardial lesions consist of perivascular, subendocardial, 
and myocardial foci of lymphocytes, lymphocytic cuffing of Purkinje fibers, occasional focal 
areas of myonecrosis, and occasional fibrinoid necrosis of arteriolar walls.286 Periglomerular 
and peritubular lymphoplasmacytic cuffs have been described in the kidney.286 
Diagnosis of the respiratory syndrome 
Diagnosis of PRRSV infection, like most infectious diseases, depends on 
demonstration of the antigen or an active antibody response coupled with the typical gross 
and/or microscopic lesions. The respiratory form of PRRS infection lends itself to this 
format, and successful demonstration of these elements is adequate. Gross and microscopic 
lesions are described above. Because these lesions may be obscured by secondary infections, 
and may also occur with other conditions, the demonstration of antigen by IHC or isolation 
of the virus are most often attempted as described below. Demonstration of PRRSV 
antibodies in serum is useful for the identification of previous exposure. 
Central nervous system disease 
Neurological disease associated with PRRSV has been described. Clinical signs were 
ataxia, posterior paresis, or convulsions in nursing and weanling pigs338 and somnolence, 
inappetance, and tremors in neonates289. Variable lymphoplasmacytic perivascular cuffing 
and gliosis were present in brain sections of nursery pigs and neonates.289-338 Porcine 
reproductive and respiratory syndrome virus antigen was demonstrated in mononuclear cells 
of the perivascular cuffs and in scattered microglial cells, and was isolated from multiple 
tissues, including brain.289-338 
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Other clinical presentations 
A syndrome characterized by multifocal to coalescing dermal necrosis associated 
with dermal and pannicular necrotizing and leukocytoclastic vasculitis accompanied by 
similar vasculitis in kidney and synovia and glomerulonephritis has been described under the 
names dermatitis-nephropathy syndrome, systemic necrotizing vasculitis and 
glomerulonephritis, and cutaneous and systemic necrotizing vasculitis.38-142-309-341-373 
Porcine reproductive and respiratory syndrome virus antigen and genetic material have been 
demonstrated in lesion-associated macrophages and lung tissues, and compliment and 
immunoglobulin complexes have been identified in affected tissues.341 These findings 
suggest that PRRSV and the systemic immune response to PRRSV may be responsible for 
this condition.341 Further studies have demonstrated PCV-2 in affected pigs, and may 
implicate that agent.128-282 The definitive cause awaits elucidation. 
With the increasing awareness of PCV-2 infection in swine, some workers have 
suggested that concurrent PRRSV and PCV-2 infections have been responsible for many of 
the pathogenic effects attributed to PRRSV alone."1 Although this remains to be defined, 
the possibility of coinfection modifying the spectrum of clinical disease and associated 
lesions must be acknowledged. 
Epidemiology 
Porcine reproductive and respiratory syndrome displays characteristics of both 
epidemic and endemic type infections.29 In its earliest manifestations PRRSV spread rapidly 
and, especially in Europe, caused severe abortion storms, typical of an epidemic. The 
reproductive form of PRRS has been shown to recur in severe outbreaks in previously 
exposed, partially immune herds, unusual for an epidemic virus in a previously exposed 
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population.29 In contrast, the respiratory form of the disease behaves as an endemic disease, 
undergoing periodic recrudescence in infected populations.29 
There is serologic evidence that PRRSV was circulating in swine in Canada and East 
Germany prior to any clinical disease outbreak.42-255 It is difficult to explain this 
phenomenon in terms of typical epidemic or endemic behavior, or indeed in light of the rapid 
spread of clinical illness worldwide. 
Although the demonstration of PRRSV in saliva and oronasal secretions, its high oral/ 
respiratory infectivity, and its rapid worldwide spread suggest aerosol spread of the infection, 
401 aerosol transmission has been difficult to reproduce experimentally. Several 
experimental trials have been conducted: 
• Intranasally inoculated pigs were commingled with naïve pigs and separated from 
susceptible pigs by an 18 inch air gap, an 18 inch air gap with a metal shield 
preventing direct movement of liquid or solid material, a 40 inch air gap, or a 40 
inch air gap with a metal shield. Seroconversion of all but I commingled pigs and 
at least 1 pig in 2 of 3, 1 of 3, 1 of 2, and 1 of 2 of the separated groups 
respectively occurred. While this demonstrated infection without direct contact, 
the transmission was neither efficient nor complete.376 
• Susceptible pigs seroconverted when separated by a l m long, 0.6m square duct 
from pigs inoculated with PRRSV strain VR-2332, but none seroconverted when 
strain MN-lb was used.344 
• Intranasally infected pigs were separated from susceptible pigs by a 50cm long, 8 
cm diameter tube. After two trials, 1 of 3 and 0 of 3 indirectly exposed pigs 
became infected. 180 
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A field investigation of an outbreak of reproductive PRRS involving a number of 
herds within an approximately 20 mile radius in Iowa during July and August of 1998 
revealed no contact or common factor, but 7 farms had virus with a 1-4-1 restriction fragment 
length polymorphism (RFLP) pattern. Genetic sequencing revealed 99.5% homology in ORF 
5 for 6 of the 7, and 96.5-98% for the seventh.177-180 The strong assumption in this outbreak 
is that this virus rapidly spread within this area, and workers suggested that aerosol 
transmission seemed likely. Be that as it may, that a viral disease could spread by putative 
aerosol transmission over extended geographical areas but could not move across a gap of 18 
inches is remarkable indeed. An as yet unidentified vector may be involved. 
Transmission in the field usually involves close contact.2-401 The spread of PRRSV 
from infected to noninfected commingled stock is more common in young animals, with 
previously infected pigs shedding virus for up to 8 weeks postexposure.176 Similarly 
exposed mature stock are less likely to become infected.176 Transmission requires transfer of 
infective materials, such as saliva or semen, and most likely requires close interactions 
between pigs.398 In field experiences, decreased population density has appeared to be 
beneficial to elimination of the virus, and may reflect decreased aggressive behaviors such as 
fighting and cannibalism.345-398 Frequently, however, in field cases no specific origin of the 
infection is determined, and the virus appears to spread in local geographical areas due to 
undetermined vectors such as vermin or birds.148-177 Attempts to identify a correlation 
between geographic location and virus strain have been generally unsuccessful and suggest 
that the various strains spread by movement of infected livestock or semen.122 
After experimental inoculation of gnotobiotic pigs at 3 weeks of age, PRRSV was 
isolated for 14, 21, 42, and 85 days from urine, serum, saliva, and oropharyngeal swabs 
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respectively, while no virus was isolated from feces or conjunctival secretions.377 Porcine 
reproductive and respiratory syndrome virus has been demonstrated in both cellular and 
noncellular fractions of milk and colostrum from lactating sows.361 
Porcine reproductive and respiratory syndrome virus has been demonstrated in semen 
of infected boars58-60-6I-126-253-307-327-382 and has been implicated in transmission between 
herds in artificial insemination programs.36-382 Transmission of vaccine virus from boars 
vaccinated with a modified live virus vaccine through semen to recipient herds has been 
implicated in an outbreak of PRRS in Denmark.36 Infection via semen was shown by 
seroconversion experimentally to be 100% efficient (n=3) at 200,000 TCID50 or greater per 
50 ml (1 insemination dose) of extended semen and 20% at 2,000 and 20,000 TCID50, while 
no seroconversion occurred with less than 200 TCID50.23 Estimates of the quantity of 
PRRSV per unit volume of semen can be made utilizing rtPCR that can identify the virus at 
concentrations of 100 TCID;o/50 ml of extended semen, a level of infection 20-fold lower 
than required for seroconversion.23-306 Following experimental infection with strain VR-
2332, virus was detected in semen for up to 92 DPI.58 Following vaccination with a 
modified-live vaccine, vaccine virus was shown to shed in semen for up to 39 DPI.59 
Vaccination with modified live vaccine reduced the duration but did not eliminate the shed of 
field virus in vaccinated boars.59-253 Inactivated PRRSV vaccines had no effect on shed of 
virus in semen.253 Previously infected boars with positive ELISA titers for PRRSV 
antibodies did not shed virus in semen on challenge with a Danish field strain.253 
Investigation of semen from intact and vasectomized boars demonstrated the presence of 
PRRSV in both cell and non-cell fractions.61 Virus was identified in macrophages and 
monocytes and indicated that virus enters the semen independently of testicular or 
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epididymal secretions, most likely from circulating monocytes or from free virus in serum.61 
Sows experimentally exposed to PRRSV intrauterinely at breeding became infected as 
evidenced by viremia and seroconversion, but the infection had no impact on the subsequent 
pregnancies in terms of number of fetuses or conception rate.181 A case-control survey of 
Danish herds did not demonstrate an increased risk of infection in herds utilizing semen from 
infected boar studs.239 In an outbreak of PRRS associated with vaccine virus in Denmark, 
however, PRRS was demonstrated to be spread through use of semen from vaccinated 
boars.36 
Increased risk of infection with PRRSV has been associated with introduction of 
boars or semen into the herd and increased herd size, while decreased infection has been 
associated with effective isolation procedures for new stock.364 
Naïve subpopulations in the breeding herd may be created by lack of internal 
exposure to allow sufficient native immunity to develop, by deterioration of immunity, and 
by introduction of naïve animals without proper acclimation.2-83-3I7-376-401 All-in-all-out 
movement of nursery pigs and finishers has a protective effect on respiratory disease in the 
breeding herd and in the nursery respectively; however, all-in-all-out movement of finishers 
was associated with higher reproductive losses in the breeding herd.123 This phenomenon 
may well represent the development of lesser immune subpopulations when the breeding 
herd is isolated from younger pigs in which PRRSV infection is active. Movement of virus 
among subpopulations may allow the infection to persist within a herd indefinitely. Recent 
indications are that PRRSV undergoes genetic drift to produce new strains within a given 
herd, allowing both endemic infection and recrudescence of clinical disease.123-178 Within 
the swine population PRRSV can demonstrate both epidemic and endemic behavior, with 
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epidemics occurring in naïve populations and simultaneous endemic infection of chronically 
infected herds.29 
The stability and survivability of PRRSV on such environmental objects as alfalfa, 
wood shavings, straw, plastic, boot rubber, stainless steel, city water, well water, buffered 
saline, swine saliva, urine, and fecal slurry has been evaluated.265 Only in the well and city 
water and saline samples did the virus persist over one day.265 Based on this study, 
transmission for any distance or time on environmental surfaces unprotected from drying 
appears unlikely. Another study demonstrated survival of PRRSV for 14 days in fecal slurry 
at 4°C and a pH of?.1 In tissues, PRRSV is rapidly inactivated at moderate temperatures.348 
At 25°C, virus was isolated from 47%, 14%, and 7% of previously viremic tissues at 24, 48, 
and 72 hours respectively.348 
Packaged retail cuts of pork comprising 438 samples were examined by virus 
isolation (VI) and rtPCR, and no evidence was found of the presence of PRRSV.188 While 
this suggests that PRRSV transmission through packaged pork is unlikely, the lack of 
knowledge of the PRRS status of the herds of origin in this study is a weak point. Other 
studies of experimentally infected pigs indicate that virus in muscle tissue is transient 
following inoculation, and appears limited to less than 14 days postexposure.203-217 When 
muscle tissue from pigs originating from seropositive herds was sampled in an abattoir, no 
virus was isolated.203 Blood, muscle, and viscera collected under abattoir conditions and 
examined by rtPCR demonstrated PRRSV RNA in blood only; although 85% of the 
examined pigs were seropositive, only 7.9% were positive by rtPCR.363 Given typical 
husbandry and PRRSV circulation within herds, it would appear that exposure during the last 
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7 to 14 days of the finishing period would be rare, and the theoretical risk of transmission 
through commercial pork products would be small. 
Transmission of PRRSV between swine and non-swine species has not been 
demonstrated under field conditions; however, mallard ducks were shown to be susceptible 
to experimental infection and shed PRRSV for up to 25 DPI in feces.400 Chickens and guinea 
fowl are also susceptible but marginally so. 224,400 Feces of experimentally exposed house 
sparrows had rtPCR demonstrable virus only at 3 DPI, and no virus was identified in feces of 
similarly exposed starlings.375 Replication of the virus in sparrows was thought by these 
workers unlikely.375 
Experimental infection of dogs, cats, skunks, raccoons, and opossums did not result in 
viremia detectable by VI techniques, but rtPCR was able to identify virus in serum, but not 
tissues, in 1 of 2 opossums sampled on 3, 11, 14, and 21 DPI and 1 of 4 raccoons sampled at 
3 DPI.375 There was no evidence of viral replication and no indication of potential carrier or 
vector status.375 Feral mice and rats trapped in an infected premises did not yield PRRSV on 
VI of serum or tissues.146 Fischer 344 rats and Balb/c mice'46 and unidentified laboratory 
rats and mice375 have not developed viremia or lesions when experimentally infected. 
Persistent infection 
A persistent state of infection has been demonstrated in pigs of several ages and under 
different conditions with PRRSV, a characteristic shared with other arteri viruses. -4- -6- -33-
268.352.378 virus can be shown to persist in macrophages of the tonsil and lymph nodes.24-27 
Persistent infection has been shown to occur in pigs bom to sows exposed to PRRSV at or 
around day 90 of gestation.24-26 Pigs in these litters which survived beyond 21 days of age 
were asymptomatic but were shown to be persistently infected as evidenced by isolation of 
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virus from tonsil as late as 132 days after birth and by rtPCR demonstration of viral RNA in 
serum as late as 210 days postpartum.24-26 Sentinel pigs became viremic within 7 days 
postexposure and seroconverted when placed in contact with these pigs between 64 and 112 
days of age, but not at 260 days of age.24 Virus has been isolated from oropharyngeal 
scrapings of infected pigs for up to 157 days PI, suggesting the tonsil as a persistently 
colonized tissue.378 Lymph nodes, tonsil, and testes have been shown to be sites of long term 
infection, although the specific mechanisms have not been defined.24-378 Seropositive, 
nonshedding 22-week old pigs have been shown to infect contact pigs with PRRSV when 
subjected to moving stress and simultaneously given exogenous corticosteroids, suggesting 
that the persistent infection can undergo recrudescence at times of stress.6 
Porcine reproductive and respiratory syndrome has shown a tendency to persist in 
production units due to the circulation of virus from older, previously exposed, asymptomatic 
pigs that are shedding virus to naïve younger pigs, and this may also occur between 
subpopulations of similar aged pigs with varying levels of immunity.2-7S-80-82-85-3I7-401 
Sentinel normal pigs commingled with nonclinical pigs four months following disappearance 
of clinical signs seroconverted within 7 to 21 days and were viremic from days 7 to 42.28 
Identification of carrier, nonclinical pigs can be done by VI of tonsil scrapings.378 An 
efficient and practical method for positive identification of carriers may depend on rtPCR, 
although the sensitivity of rtPCR has been shown to be 68.8% in one study of samples from 
acutely infected animals, a less than desirable level.362-399 
The duration of persistence of PRRSV in these pigs has not been established. When 
pigs were inoculated with PRRSV at 3 weeks of age, virus could be demonstrated or 
recovered in 90% of the subjects sacrificed at the 105 DPI terminus of the trial.147 Infection 
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that persists beyond 180 days is essentially life-long in market swine. In breeding swine, a 
persistently infected boar was placed with 3 noninfected gilts for 56 days; seroconversion of 
the gilts did not occur, and the pigs from the resulting litters were normal.26 This apparently 
demonstrated elimination of the infection in this individual; however, more study will be 
needed before generalizations can be drawn. 
No method of identification of persistently infected individuals has been established, 
but rtPCR of tonsil tissues has been suggested.26-398 Isolation of virus from infected pigs 
more than 35 days from the first appearance of clinical signs is suggestive of persistent 
infection.26 
Immunity 
Humoral immunity 
Maternally derived passive immunity wanes by about 6 to 10 weeks of age. In 
actively infected herds, this diminution in antibody levels corresponds to the highest level of 
clinical disease.2-65 The half life of passive antibody is short, with pigs at 2-8 days of age 
being 2.8 times more likely to be positive than pigs 9-10 days of age in one study.94 
Antibodies to PRRS virus are detectable by indirect fluorescent antibody (IFA) test 
about one to two weeks following infection and by ELISA test by about 6 to 7 DPI and 
persist up to 1 year.237-249-394. Typically, a rapid increase in titer is seen for approximately 4 
weeks, followed by a period of generally stable titers from about 4 to 8 weeks PI.3'7 During 
the next 4 weeks titers decline rapidly followed by a more gradual decline out to 4 to 8 
months PI.3'7 In infected sows, antibody has been detected as long as 604 DPI by IF A test.176 
IgM antibody can be demonstrated earlier and disappears earlier than IgG antibody, and may 
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provide a method for earlier detection of exposure and estimation of time since exposure.152-
359 
Neutralizing antibody is generally reported to be initially demonstrated by 4 to 5 
weeks post infection, peak by about 70 DPI, and persist to about 356 DPI by modified serum 
neutralization tests.3S9-394 These data are consistent with a number of reports.28-56-70-l72-194-
249,359 Later research, however, has found that development of virus neutralizing antibody 
did not occur until 11 to 13 weeks PI.209 The reason for this difference is not clear, but may 
be due to a variation in response related to the viral strain. Variation in the time of detection 
of neutralizing antibody has also been related to the test procedure; incubation of samples 
with added complement has demonstrated neutralizing antibody 2 weeks PI.156-329 
The most immunodominant of the proteins comprising PRRSV is the 15-kDa 
nucleocapsid protein N encoded by ORF 7.394 This dominance of the ORF 7 protein product 
as an antigen may be more associated with its relative abundance rather than its 
antigenicity.194 This is in contrast to the response of equids to EAV, in which the membrane 
protein appears to be the most antigenic protein. 199 Disruption of the carboxy terminal 
structure of this protein results in loss of antigenicity and identifies this terminus as the 
primary epitope.380 Antibody to this protein was detected earlier and persisted longer 
compared to antibodies against the 19 kDa M protein and the 25 kDa glycosylated membrane 
protein, but failed to demonstrate serum neutralizing characteristics.394 Virus-neutralizing 
antibody is more associated with the protein product of ORF 5394 l24-171- 365,383^ and has 
been linked to ORFs 4 and 6 as well.171-383 Subunit vaccines produced utilizing the N 
protein for antigen were poorly protective against reproductive disease as indicated by the 
low (16.6%) proportion of pigs born alive and healthy, while those using the gene products 
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of ORPs 3 and 5 (GP3 and GP5), which stimulate the production of neutralizing antibody, 
were more protective, with 68.5% and 50% of the pigs alive and healthy respectively.271 
The level of protection provided by circulating nonneutralizing antibody is unclear, 
based on the observation of viremia in the face of high antibody levels 283and the presence of 
antibody-dependent enhancement (ADE) of infection.390 Antibody-dependent enhancement 
occurs through increased uptake of antibody-complexed virus by macrophages, mediated by 
the Fc receptor.237- 39°-391 Antibody-dependent enhancement occurs when the level of 
circulating antibody falls below neutralizing levels which occurs during normal decay of 
passive maternal antibody level or active immunity following exposure.390 This may explain 
the susceptibility of pigs in the 5 to 8 week age when maternal antibody is disappearing. 
Antibody-dependent enhancement has been demonstrated to occur with a number of viruses, 
including dengue, feline infectious peritonitis, equine infectious anemia, and Aleutian disease 
viruses.390 The level of enhancement is variable among different strains of PRRSV, and may 
be a factor in the field-observed relationship between outbreaks and vaccination due to 
enhancement of infection by field virus through interaction with vaccine-induced 
immunoglobulin.391 The 26-kDa envelope protein appears to be associated with this 
phenomenon.390 Experimental inoculation of 17-day-old pigs with detectable maternally 
derived antibody protection resulted in extended viremia and increased severity of clinical 
disease as compared to similarly exposed specific pathogen free pigs without maternal 
protection.300 This study is consistent with ADE and may explain severe PRRSV respiratory 
outbreaks in weaned pigs from exposed or vaccinated sows. 
A challenge study using PRRSV strain NADC-8 demonstrated that exposure on 
gestation day 1 had no effect on the fetus, and that the resulting immune response protected 
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against reinfection when the gilts were reexposed to the homologous strain at a later time in 
that pregnancy.183 This protection was demonstrated to protect against homologous challenge 
for up to 604 DPI in breeding stock.176-182 Protection against reinfection with homologous 
virus has been demonstrated against respiratory disease in young (15 week) pigs.302 
Protection against heterologous challenge is less complete and likely is dependent on the 
relative similarity of the challenge strains.184 This evidence suggests that prebreeding 
exposure during the acclimation phase of new breeding stock to PRRSV endemic on a given 
premises should help protect against reproductive disease. This contention is borne out by 
field studies.80-8'•84 
The systemic response to acute PRRSV respiratory infection includes increases in 
serum IL-6 and haptoglobin, an acute phase protein; TNF-a and a-1 acid glycoprotein were 
not demonstrated to increase in this study.14 In lung lavage fluids, IL-1 was detected from 3 
through 10 DPI, while interferon-a and TNF-a levels were minimal and nondetectable 
respectively.354 
Cell mediated immunity 
A well-developed cell mediated immune (CM!) response to PRRSV challenge has 
been demonstrated.19-159-l96-294-29s-304-402 This response was detected at 4 weeks PI, 
peaked at 7 weeks, and declined from 11 weeks.19 On rechallenge, an anemnestic response 
occurred.19 Field strains of PRRSV have been demonstrated to induce a CMI response that 
persists longer than 1 year.402 Modified-live PRRSV vaccine induces a similar but less 
intense response 402 In infected pigs, the populations of T-cytotoxic (Te) (CD8+) 
lymphocytes have been shown to increase in systemic lymphoid tissues, while B-cell 
populations increased in mucosa-associated lymphoid tissues (MALT).159 In vitro studies 
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show increases in CD4+CD8+ and CD4-CD8+ populations accompanied by decreases in 
CD4+CD8- populations in peripheral blood mononuclear cells from PRRSV-infected pigs.196 
In vivo studies have shown similar increases in the percentage of circulating mononuclear 
cells with Tc markers (CD4-CD8+).294-295 T-cell populations have been demonstrated in 
vivo to have a cytokine production pattern typical of Tul-type cells- that is, they tend to 
produce cytokines such as IL-2 and IFN-y, which activate Tc cells.196 Addition of porcine 
leukocyte blocking antibodies to cell cultures demonstrated that the response is highly 
dependent on CD4+ (TH) cells.'9-196 Blocking CD4+ receptors reduced the in vitro T-cell 
proliferation response by 80%.19 Blocking CD8+ cell receptors and monocyte receptors 
reduced the response by about 50 and 55% respectively, while no inhibition was observed 
when B cell receptor blockers were introduced.19 Cellular immunity has been demonstrated 
in vivo by a delayed-type hypersensitivity reaction following intradermal injection of 
inactivated viral particles in sensitized animals which was noted to peak in 24 hours and 
decline by 72 hours PI.'9 
Changes in the ratio between CD4+ and CD8+ T-cells have been described in 
infected pigs.304 CD4+ cells were shown to decrease significantly in early infection.304 The 
significance of this observation is obscure, and although such a change would be indicative 
of immune system dysfunction, the transient nature of this change does not support such 
conclusions. By day 3 PI, changes were demonstrated in lymphocyte populations, with a 
significant decrease in CD2-r, CD4+, and CD8+ cells.251 CD2+ and CD8+ cells returned to 
preinoculation or slightly (but nonsignificantly) increased values by day 5; CD4+ cells 
remained relatively lower through day 14.251 
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Cell mediated immunity may be significant especially considering the presence of 
viremia in the face of nonneutralizing antibody levels. Antibody which neutralized viral 
infectivity in cell line CL 2621 failed to protect PAMs, and, in fact, antibody has been shown 
to enhance uptake of virus by PAMs, as mentioned above.19'390 
Demonstration of immunosuppression by PRRSV has not been successful, even 
though frequently hypothesized. Although PRRSV exposure has been shown to cause a 
short-term decrease in circulating leukocytes between days 2 and 4 consisting of decreased 
CD4+, -2+, and -8+ lymphocytes, values returned to preexposure levels by day 8 to 10, and 
thus did not indicate significant long-term immunosuppression.251-304 The apparent 
immunosuppressive behavior of PRRSV may be associated with its tropism for and negative 
effects on both pulmonary and circulating macrophages.100-336-337-340 A corresponding 
decreased proliferative response in blood lymphocytes to in vitro stimulation by mitogens 
was transiently observed at 3DPI, but quickly resolved, and by 14 DPI, proliferative 
responses were significantly enhanced.359 Levels of CD4+, -2+, and -8+ lymphocytes have 
been shown to be increased by 3 weeks PI, and subsequent response to vaccination with PRV 
vaccine was not shown to be suppressed by antibody titer or CMI response, while 
postvaccination challenge with virulent PRV stimulated increased levels of anemnestic 
response in PRRSV infected pigs as compared to controls.7 
Hematology 
Total leukocyte, neutrophil, and lymphocyte values have been shown to decrease 
significantly by 3-4 DPI in 4-month-old pigs, but returned to normal values by 8- 10 DPI.251 
In a preliminary study of 4-week-old gnotobiotic pigs infected with several strains of 
PRRSV, slight decreases in red blood cell count, hematocrit, and hemoglobin levels were 
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observed, although the magnitude of the change was strain-dependent.281 Values returned to 
normal by 21 DPI.281 Eosinophil counts were slightly increased, monocytes were decreased, 
and lymphocytes and neutrophils were not significantly changed.281 The bone marrow 
myeloid: erythroid ratio was increased between 3 and 10 DPI; however, the magnitude of 
these changes also appeared to be strain dependent.281 These changes may reflect the affects 
of cytokines released due to inflammation associated with PRRSV infection, although the 
results of this study281 have not been confirmed. Cytokines are known to decrease erythroid 
activity.107 
Detection of PRRSV Antibodies 
Detection of PRRS antibody has been done by indirect fluorescent antibody (IFA), 
immunoperoxidase monolayer assay (IMA), enzyme-linked immunosorbent assay (ELISA), 
and serum virus neutralization (SVN) tests.5,37*5I -77,92*254>312-328'330-379> 388-389>394 The 
ELISA test has demonstrated a high level of sensitivity and specificity relative to the IFA and 
IMA tests,53 and may provide the most reliable means of detecting exposure since several 
antigens are present in the most commonly used commercial ELISA test (HerdCheck® 
PRRS, IDEXX Laboratories, Westbrook, ME) which cover a broad range of serotypes.52 The 
ELISA serum/positive (S/P) ratios for animals from negative herds have been shown to 
group significantly toward zero, indicative of the low background rate inherent in the IDEXX 
test.114 Sensitivity and specificity have been demonstrated as high as 94% and 97% 
respectively for the IDEXX ELISA test, but lesser values were demonstrated in specific sets 
of paired sera.254 An ELISA test using recombinant nucleocapsid protein product of ORF 7 
was shown in one report to be 100% sensitive and 95.8% specific in identification of some 
700 positive and an approximately equal number of negative samples due to the conserved 
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nature of that protein.92 For the detection of PRRSV antibody on a herd basis, an ELISA test 
has been run on blended samples of serum and on blended and individual serum samples 
eluted from dried blood collected on filter paper.149 These procedures were as sensitive as 
the more traditional serum sample tests in detecting infected herds, and were less costly in 
collection and shipment.149 ELISA tests have also been developed to differentiate between 
European and American strains of virus.312-313 
The IFA test is typically run to detect IgG antibody; however, an IFA used to detect 
IgM antibody was able to detect antibody sooner (day 5 vs. day 9) and returned to negative 
earlier (day 28 vs. day 63+) than IgG- based IFA in 3-week-old pigs.259-359 The IgM test had 
a higher degree of correlation with viremia than the IgG based test (81.3% vs. 59.3%).259 
Thus it has been suggested that an IgM based test may be useful to detect infection sooner, 
and may provide a more rapid estimate of the likelihood of viremia without the delay of VI 
testing.259 Colostrum has also been demonstrated to be a satisfactory sample for IFA 
detection of PRRS antibody, with a correspondence of about 92% to the IFA serum 
values.110 
The immunoperoxidase monolayer assay using test serum as a primary antibody 
relies on attachment of secondary antibody conjugated to peroxidase for the development of 
typical color changes in fixed monolayers of MARC-145 cells.328 The technique appeals to 
be comparable in results to IFA examination.328 
The immunoperoxidase monolayer assay and a double blocking ELISA test have 
been adapted to differentiate between European and American or vaccine strains.37-313 
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Detection of PRRSV Antigen 
Virus isolation is done using lung, lung lavage fluid, serum, tonsil, or other tissue 
homogenates cultured on porcine pulmonary alveolar macrophages or the MARC-145 cell 
line, 33-68'l63-218-227 although other cell lines, such as CL 262118 have been utilized. A table 
listing available cell lines has been published.212 Alveolar macrophages flushed from the 
lung may be lysed and cultured for virus, or incubated on culture media and examined by FA 
test.217 Alveolar macrophages are the normal target cell and are the most sensitive cell line 
for isolation of field strains.'8-301 Vaccine strains are cell-culture adapted and will grow 
more readily in cell culture lines such as MARC-145 than in PAMs.223-274 However, these 
strains will recover their ability to grow in PAMs within two passages.37 
Virus can be cultured from serum or tissues of affected pigs, and serum from 
presuckled pigs can be examined for the presence of virus or antibody; however, fluids or 
tissues from aborted, autolyzed fetuses are poor subjects for VI.2'7-348 Storage of tissues at 
4° C for up to 72 hours has been shown to have little impact on recovery of the virus, but 
virus recovery was reduced to 47%, 14%, and 7% of the tested tissues at 24, 48, and 72 hours 
respectively when tissues were stored at 25°C.348 The half-life of PRRSV in tissue culture 
was reduced from 140 hours at 4°C to 20 hours at 21, 3 hours at 37°C and only 6 minutes at 
56°C.31 
Immunohistochemical staining and ISH techniques allow demonstration of PRRSV 
antigen or nucleic acid in fixed tissues through labeling with monoclonal antibodies or a 
DNA probe respectively.33-47-62-l34-13i-l86-l87-202-338 These techniques not only allow 
detection of virus when only fixed tissues are available, but also allow identification of the 
affected cells or areas. Use of ISH techniques coupled with rtPCR for detection of minute 
amounts of antigen is promising. A comparison of ISH and IHC (immunogold) revealed ISH 
to be more sensitive, identifying antigen in 70.4% vs 52% of examined tissues from 
experimentally infected pigs, and in 83% vs. 74% of field cases of necrotizing and 
proliferative pneumonia.186-187 The decreased sensitivity of IHC may be due to formalin 
fixation which causes crosslinking and a loss of available epitopes for IHC procedures; 
however, RNA and DNA are well preserved by this fixative, and RNAase activity during 
processing is inhibited.187 In addition, ISH identification of nucleic acids will allow 
detection of viral elements earlier in the virus assembly, and will detect both intact virions 
and unassembled elements, thus increasing the amount of potentially identifiable material.324 
Early in infection, there is a close correlation between ISH detection of RNA and IHC 
detection of nucleocapsid protein, while later in infection (beyond day 28) more RNA than N 
protein is apparent.324 An immunofluorescence ISH procedure has been reported to 
demonstrate virus in salivary gland and skin as well as more typical locations.62 
Reverse transcription nested polymerase chain reaction (rtPCR) has been used to 
identify PRRSV genetic material in various tissues and can be used to differentiate among 
genotypes.37-60-6I-121-132-166-206-248-256-315-323-362 A similar procedure utilizes rtPCR 
coupled with colorimetric assay rather than electrophoresis as the detection method.193 
Utilizing the gene product of ORF 7, the nucleocapsid protein, allows the greatest degree of 
sensitivity due to the highly conserved nature of that component.37-132 Reverse transcription 
PCR has been used to generate cDNA probes for in situ hybridization that allows 
identification of antigens in fixed tissue.121-166*IS9-324-378 Reverse transcription PCR can be 
utilized with serum, plasma, and whole blood-impregnated filter paper discs as samples, and 
has demonstrated greater sensitivity than virus isolation.315 In addition, virus can be 
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demonstrated by rtPCR as early as 24 hours PI, some 7 days before detectable antibody.315 
Because rtPCR amplifies available genomic material, rtPCR gives the added advantage of 
detecting very limited quantities of virus.55 As few as 10 virions per milliliter were detected 
in semen by rtPCR.55 The rtPCR detection level for PRRSV in semen has been estimated at 
approximately 20 fold below the minimum infectious dose required for seminal 
transmission.23 Differentiation between European and American strains of PRRSV has been 
proposed based on rtPCR assay of a portion ofORFs lb and 7.121-166 
Monoclonal antibodies (Mabs) directed against both the N and M proteins have been 
utilized to distinguish between strains of PRRSV.102- 20°-201-250 Monoclonal antibodies 
EP147 and V017 raised against the 15-kDa nucleocapsid protein, and Mab 2C12 raised 
against the 19-kDa membrane protein, were able to distinguish American and Canadian 
isolates from European isolates, suggesting that the M and N proteins are highly conserved 
among American and Canadian isolates but differ from European isolates.200-201 Analysis of 
the genetic sequences of ORF 6, encoding the M protein, and ORF 7, encoding the N protein, 
support these findings.211 This study demonstrated 97-100% homology of ORF 6 and 7 
among US and Canadian isolates, while these isolates compared to LV demonstrated 57-59% 
and 78-81% homology for the M and N genes respectively.211 Both conserved epitopes and 
divergent epitopes have been identified on the 15 -kDa N protein by Mabs.250 Monoclonal 
antibodies SDOW17 and SDOW12 identify conserved portions of the N protein, and react 
with both North American and European strains, while V017, V022, EP147, and EP160 
identify only North American strains.74- 2O°-250 Monoclonal antibodies raised against protein 
products of ORFs 2-7 have been used to group viruses with an IF A test for identification or 
classification of virus strains in epidemiological studies.384 Antibodies raised against N-
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protein epitope EpORF7-A may be the broadest in application due to the conserved nature of 
that sequence among strains.385 Studies suggest that the 11 amino acids at the carboxy 
terminus of the nucleocapsid protein are necessary for proper conformation of the antigen.380 
A strain of virus similar in reactivity to the LV has been isolated in Ontario, Canada, 
and designated ONT-TS.119 Comparing the results of IF A obtained with SDOW17, V017, 
EP147, and IAFK8 directed against the N protein and IAFK.3 and IAFK6 directed against the 
M protein of ONT-TS demonstrated a similar pattern to LV.119 However, amplification of 
the ORF 6 and 7 regions of this isolate demonstrated similar sequencing to the North 
American isolates.119 
Differentiation of field isolates from vaccine strain used in ResPRRS Repro (Noble) 
and its prototype strain ATCC VR-2332 has been described using restriction fragment length 
polymorphism (RFLP).11S-371 The RFLP patterns have been shown to be relatively stable, 
but due to the genomic shifts typical of PRRSV, intermediate patterns between vaccine and 
field virus types can emerge over time.228*372 There is a potential in the RFLP procedure for 
masking of a field virus by concurrent infection with cell culture adapted vaccine strains, 
which grow preferentially in cell culture during the initial stage of the RFLP procedure.223 
Use of a nested-set rtPCR procedure rather than a nonnested procedure during the RFLP 
processs eliminates the propagation step and reduces this potential, as well as reducing labor 
and time involved.225-346 
Flow cytometry has been used to identify macrophages and monocytes infected with 
PRRSV. This technique has the additional advantage of dual staining of cells for the 
detection of both viral antigens and cell-type identifying surface markers.332 
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Economic Effects 
Even when clinical disease from PRRSV infection is limited, the presence of the virus 
is a distinct disadvantage during the feeding period.162-275 Loss in total profitability from 
PRRS is difficult to assess, but records from affected herds reflect losses from $5 to SI8 per 
pig. 162- 275 Sequential infection with PRRSV and swine influenza virus were reported to 
cause a loss of approximately £7 per pig in a British report.160 Early estimates of economic 
loss were set at S236 per sow per year276 and have been estimated to vary from S.73 to 
S 18.21 per head in nursery pigs.275 
In breeding herds, parameters adversely affected by PRRS include average parity, 
pigs per litter (total, stillborn, and weaned), preweaning mortality, and replacement and 
culling rates. 21- —•40 Loss has been estimated at £65/sow/yr.40 Analysis of specific herds 
have demonstrated significant increases in farrow to weaning death loss (6% preinfection vs. 
as high as 80% postinfection per weekly period, with an overall loss in a four month period 
of 50%), and a fourfold increase in death losses in weaned pigs, during an acute outbreak in 
Poland.263 Farrowing rates dropped from 80.5% to 47.7%; 25.6% of sows farrowed prior to 
day 110 of gestation; and medication and treatment expenses were 60% higher than the 
previous comparable period.262 
Prevention 
Vaccines developed for the induction of protection against PRRSV have been 
introduced and have been shown to protect against homologous strains, with variable results 
on heterologous challenge.143-144-207 Vaccination with either American or European virus 
strain origin vaccines has given protection against the homologous (ie., American or 
European) challenge strains, but gave poor protection against heterologous strains.173-356-357 
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Interestingly, in Danish sows previously exposed to the European strain that were vaccinated 
with the US strains, an anemnestic response resulted in titers to the European strain in excess 
of those to the US strain.35 Vaccination of young (3-4 weeks of age) pigs was shown to 
produce increased IF A titers in pigs with low or high maternal antibody levels, but was less 
successful in pigs with moderate levels of maternal antibody.358 The induction of immunity 
in the face of maternal antibody may be due to the opsonising effect of immunoglobulin on 
PRRSV and the influence of antibody-dependent enhancement of infection.358-390 
Simultaneous vaccination of all susceptible animals with two doses of MLV vaccine 30 days 
apart coupled with unidirectional movement of vaccinated, seropositive pigs has resulted in 
elimination of infection in weaned pigs.90 Vaccination with PRRSV vaccine has been shown 
to protect against homologous and heterologous challenge in breeding swine when 
administered 30 days prior to challenge, and appears to cause an anemnestic response in pigs 
previously exposed to heterologous strains;35however, this protection is not complete.221 
Production of infectious transcripts of genome-length complimentary DNA (cDNA) 
has been accomplished, and specific mutations can be inserted within the genome.230 This 
may enable production of genetically altered vaccines that may prove more efficacious 
and/or safe. In addition, genetically altered EAV containing PRRSV ORF 2 through 7 
sequences has been experimentally produced, which may allow production of vaccines that 
will stimulate antibody distinguishable from field immunity.316 Experimental vaccination 
with products of ORFs 3 and 5 demonstrated protection against PRRSV abortion and fetal 
infection in sows; however, the product of ORF 7 was nonprotective.269 Vaccination with 
plasmid DNA corresponding to ORF 5 has also stimulated anti-GP5 neutralizing antibodies 
in pigs and laboratory mice.75-266 In pigs, both cellular and humoral responses were 
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identified following vaccination with plasmids containing cDNA corresponding to ORFs 4 
through 7.171 Antigenic epitopes of other viruses can be inserted into ORF 7, allowing the 
use of PRRSV as a vector.129 
Inactivated vaccines have been shown effective and safe in European and American 
trials, and avoid the danger of recrudescence,270 but fail to reduce shed of virus in semen.253 
Virus from modified live vaccine has been demonstrated to be shed and to infect 
contact animals.314 In addition, evidence for persistence and return to a less attenuated state 
has been demonstrated for vaccine virus.228 Vaccinated swine in breeding herds in Denmark 
displayed severe reproductive losses following vaccination with a vaccine newly approved 
by Denmark containing a modified strain of the American type virus.36 Viral isolates were 
traced genetically to the vaccine virus and demonstrated shifts in the sequences of ORF 5 and 
7.319 Vaccine virus was also shown to be spread through semen from boar units providing 
semen for artificial insemination.36 This is consistent with experimental demonstrations of 
semen shedding of virus in natural infections 12f>-382 and following vaccination.59-314 
As mentioned previously, vaccine virus has been shown to infect pigs in utero and 
may adversely affect these pigs in the postnatal period.220 Vaccination of breeding stock at 
any time during gestation has been shown to adversely affect the number of pigs bom alive 
and weaned and to increase stillborn and mummified pigs.95 This effect was most 
pronounced when vaccine was administered during the last month of gestation or concurrent 
with clinical PRRS.95 Other studies however have not shown significant added losses in 
midgestation vaccinated sows.221 
Administration of MLV PRRSV vaccine prior to infection with Streptococcus suis 
has been shown to increase disease and death loss.133-336 Vaccination with MLV PRRSV 
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vaccine or infection with virulent PRRSV have negative effects on the efficacy of 
Mycoplasma hyopneumoniae vaccine.334-335 Although Mycoplasma hyopneumoniae vaccine 
reduced the severity of pneumonia in pigs subsequently infected with M. hyopneumonia and 
PRRSV, simultaneous vaccination for both agents negated this advantage.334-335 In those 
cases where PRRSV has been eliminated from infected herds, cessation of vaccination with 
modified live products has been cited as an important factor, although initial vaccination is 
helpful in establishing herd-wide immunity.264-345 
Simultaneous inoculation of two modified live PRRSV vaccines, RespPRRS/Repro® 
(Boehringer Ingelheim NOBL) and Prime Pac PRRS® (Schering Plough), into MA-104 cell 
cultures has resulted in the production of new strains of virus derived from the two parent 
viruses by recombination.116 The possibility of such recombination in vivo suggests that 
simultaneous administration of more than one vaccine may be detrimental. Recombination 
between vaccine and field viruses may also be possible but has not been definitively 
demonstrated.116 
Although vaccinated pigs have been shown to be less susceptible to respiratory 
disease 207, economic studies have cast doubt on the benefits of routine vaccination, and 
suggest that diagnostic investigation demonstrating a specific need is necessary prior to 
instituting a vaccination program.39 
Management techniques focused on prevention of circulation of virus within a herd 
by establishment of uniform breeding herd immunity by acclimation of breeding stock and 
isolation of groups of pigs by age have proven successful in reducing the incidence of 
infection and economic loss.78-85"87-l23- 28°-345 As the virus may be transmitted by contact 
with infected saliva, management techniques that focus on reduction in mixing pigs and 
avoid crowding and/or fighting should prove helpful.123-345-398 Segregated early weaning 
(SEW) techniques have been used to remove pigs with maternal immunity prior to exposure, 
but the success of this method depends more on high breeding herd immunity, lack of 
circulating virus in the farrowing house, and prevention of persistently infected 
subpopulations than on immune status of the pigs.26-97-280 In regions of low pig density and 
limited prevalence, restrictions on pig movement and monitoring of semen stocks for PRRSV 
has been successful in controlling the spread of the disease.192 Although spontaneous 
disappearance of PRRSV infection from a herd has been reported, this is not a common 
phenomenon and cannot be anticipated.117 Removal of infected stock has been suggested and 
has been shown to be effective on a herd basis.88-89 It is likely that a high level of 
management, biosecurity, and one-way flow of animals would be necessary to achieve the 
desired results.88-89 Protocols have been suggested for the development of PRRSV-negative 
herds from PRRSV-positive sources, and given adequate management and strict adherence to 
isolation and handling procedures may prove of value.280-343 Strict observation of one-way 
pig flow and multisite production will likely be required for practical success. Study of long-
term carrier status in pigs show that 90% of infected pigs were carrying virus at 105 DPI.147 
Although the dynamics of the carrier or persistent state are not yet fully described, the 
implications of current knowledge are that elimination and control within positive 
populations may be an exercise in diminishing returns. In eradication programs, immune 
stability of the sow population was shown to be important as might be expected; the presence 
of nonimmune subpopulations would reasonably allow circulation of active infection.2-9-30-
83,2S0,317.376,401 Separation of the various age groups (farrowing, nursery, grower, finisher) 
and control of traffic between the various units is also important.9-30 
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Conclusion 
Porcine reproductive and respiratory syndrome continues to be a major cause of 
swine disease and economic loss. Management of the breeding and growth phase herds plays 
a major role in control of the disease. In order for the swine producer to adequately manage 
and make well-informed decisions, it is imperative that a diagnosis be established. 
Techniques for this purpose are a major component of this research. 
Vaccination is widely practiced but has had numerous drawbacks, not the least of 
which is the cost of vaccine and its administration. Disease outbreaks in vaccinated herds 
frustrate the producer and the attending veterinarian. An assessment of the degree of 
protection provided by vaccination and its relationship to exposure dose are also to be 
investigated here, and will assist in evaluating the advisability of vaccination as a 
management tool. 
Aside from these practical applications which need to be addressed, the effects of 
PRRSV infection on progesterone levels and ovarian tissues are aspects of PRRSV which are 
not yet fully explored and will be examined in this research. 
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CHAPTER 3. EFFECT OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS (PRRSV) EXPOSURE DOSE ON FETAL INFECTION IN 
VACCINATED AND NONVACCINATED SWINE 
A paper published in Swine Health and Production1 
James E. Benson, Michael J. Yaeger, Kelly M. Lager 
Summary 
Objective: To evaluate the relative susceptibility of vaccinated and nonvaccinated 
pregnant swine to varied challenge doses of porcine reproductive and respiratory syndrome 
virus (PRRSV) and the potential for increased challenge doses of PRRSV to overcome 
vaccine-induced immunity. 
Method: Fifteen nonpregnant gilts obtained from a PRRS-free herd were vaccinated 
twice with a modified-live PRRSV vaccine prior to artificial insemination. At 90 days of 
gestation, these VACC-CHAL gilts and 16 pregnant, nonvaccinated CHAL sows were 
randomly allotted to one of four experimental groups: a control group that received a sham 
inoculation, or to groups that received a "low" (102 CCID50), "middle" (104 CCID50), or 
"high" ( 106 CCID50) dose of an intramuscular challenge of the NADC-8 PRRSV strain. 
Results: The number of infected litters in all dosage groups was significantly higher (P<.001) 
among CHAL females compared to VACC-CHAL females. Dead fetuses and viremia were 
observed in all litters in the low- and middle-dose groups, and in three of four litters in the 
high-dose group in the CHAL females; and in no low-dose litters, one of two middle-dose 
litters, and one of four high-dose litters in the VACC-CHAL females. No fetal death or 
viremia was identified in control groups. Among infected litters, no significant difference in 
' Reprinted with permission of Swine Health and Production. 2000, 8 (4), 155-160. 
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the percentage of infected fetuses per litter was observed regardless of vaccination status or 
challenge virus dose. The number of litters with fetal death and infection was significantly 
lower in the low-dose VACC-CHAL group when compared to the low-dose CHAL group 
(Pc.Ol), but no significant difference was demonstrated between the two medium or two 
high dose groups. 
Introduction 
Although the practice of vaccinating breeding stock against porcine reproductive and 
respiratory syndrome virus (PRRSV) is widespread in the United States swine industry, 
PRRSV-induced losses continue to occur in some PRRS-vaccinated herds.1,2 In the field, 
these losses may be interpreted as vaccine failure or inefficacy. Strain variation in field 
viruses, suboptimal vaccination procedures, concurrent stress or disease, and nutritional 
factors have been related to such failures for vaccines in general,3 and these factors could 
reasonably be expected to affect the response to PRRS vaccination. One can also encounter 
variation in the exposure dose of field virus during PRRS epizootics. While vaccination may 
provide protection against a minimal to modest exposure, high doses of field virus may 
potentially overcome immunity.3 
This study was designed to assess the impact of varied PRRSV exposure doses on the 
susceptibility of sows to infection, clinical disease, and PRRSV-associated reproductive 
disease, and to determine whether exposure to a higher challenge of PRRSV may be a 
potential factor in the failure or inefficacy of vaccine-induced protection against PRRSV. 
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Materials and methods 
Animals 
Thirty-one breeding females were used in this study. Fifteen 10-month-old 
nonpregnant gilts ("VACC-CHAL" females) and 16 naturally mated 1.5- to 2-year-old 
pregnant sows ("CHAL" females) were procured from the same commercial herd, which was 
deemed free of PRRSV based on clinical and serological history. All animals were found to 
be serologically negative for PRRSV antibody prior to arrival. On arrival (Study Day 0), they 
were randomly allotted to study groups, acclimated for 14 days in climate-controlled indoor 
isolation units at Iowa State University, and then retested for PRRSV antibody by 
commercial ELISA test (HerdChek|RI PRRS, IDEXX Laboratories; Westbrook, Maine) 
(Table I). 
After acclimation, VACC-CHAL gilts were vaccinated with 2 cc of a modified-live 
PRRSV vaccine (RespPRRS Repro(TM), Noble Laboratories Inc.; Sioux Center, Iowa) via 
intramuscular (IM) injection 126 and 112 days before challenge. On study day 29, estrous 
synchronization was initiated. Gilts were given 6 cc altrenogest oral solution (Regu-MatelR), 
Hoechst-Roussel Agri-Vet Co.; Somerville, New Jersey) in a small amount of feed, 
providing 13.2 mg altrenogest per head once daily for 28 consecutive days. On day 93 pre­
infection (study day 47) each gilt received one IM dose (5 mL) of PG600(R) (Intervet Inc.; 
Millsboro, Delaware) to provide 400 IU of pregnant mare serum gonadotropin and 200 IU of 
chorionic gonadotropin per dose. Thirty hours later, gilts were given 750 USP units of human 
chorionic gonadotropin (hCG) (Follutein(R), Solvay Animal Health, Inc.; Mendota Heights, 
Minnesota) by IM injection. Gilts were mated twice by artificial insemination at 24 and 36 
hours after the hCG injections (91 and 90 days prior to infection) with semen from a PRRSV-
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negative boar. On day 36 of gestation (54 days prior to infection), 14 of the VACC-CHAL 
gilts were verified as pregnant by real-time ultrasonography. 
CHAL sows were naturally mated to PRRSV-negative boars, and were pregnant 
when they were placed in the isolation facilities. They received no vaccine. 
Virus challenge 
The NADC-8 PRRSV strain was prepared as previously described.4 Briefly, the virus 
was isolated from serum of a weakbom pig on MARC-145 cells. The cell culture was frozen 
and thawed and the virus was serially passed two more times. The third passage of virus was 
titrated and diluted with serum-free minimal essential medium to prepare the low (10" 
CCID50), medium (104 CCID50), and high (106 CCID50) challenge virus inoculum (2 mL 
volume). A virus-free control sham inoculum was prepared in a similar fashion from 
uninoculated MARC-145 cells. Heterogeneity between challenge and vaccine virus was 
based on temporal and geographical differences when viruses were isolated2* and genetic 
differences between the challenge virus and VR-2332 PRRSV strain," the parental strain of 
vaccine virus that has a 99.7% nucleotide homology with ORFs 2-7 sequence of the vaccine 
virus.b 
At 90 days of gestation (0 days post-infection [DPI]), the 14 VACC-CHAL gilts and 16 
CHAL sows received one of four challenge exposures to PRRSV injected IM in the caudal 
thigh: 
• a sham inoculation ("control" group); 
• 102 CCID50 of PRRSV ("low-dose" group); 
• 104 CCED50 of PRRSV ("middle-dose" group); or 
• 106 CCID50 of PRRSV ("high-dose " group). 
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Sampling 
Animals were monitored daily for clinical signs and pyrexia. Blood samples were 
collected via jugular venipuncture from all females on the day of challenge (0 DPI), 7 DPI, 
and 21 DPI. The serum was separated within 2 hours and frozen at -70 degrees C. All sera 
were evaluated for PRRSV antibodies by the ELISA test and for PRRSV by virus isolation at 
the completion of the trial. All animals were euthanized at 21 DPI, and the following 
maternal tissues were collected: cerebrum, cerebellum, pituitary, tonsil, lung, liver, kidney, 
spleen, uterus, ovary, and oviduct. Sow lungs were lavaged to collect porcine alveolar 
macrophages as previously described.7 At necropsy, fetuses were sequentially numbered 
beginning at the tip of one uterine horn. Fetuses in spontaneously aborted litters were 
numbered at random. Thoracic fluid was taken from dead fetuses and serum samples from 
live fetuses. The serum was separated and the serum and thoracic fluid were stored at -70 
degrees C. The following tissues were collected from all fetuses: brain, lung, cardiac muscle, 
aorta, liver, spleen, tonsil, placenta, umbilical cord, and mediastinal lymph nodes. Maternal 
and fetal tissues were examined for gross and microscopic lesions. 
All fluids (fetal sera and thoracic fluid and sow/gilt sera and lung lavage fluid) were 
used for isolation of PRRSV as previously described.8'9 Briefly, cultured cells of the MARC-
145 cell line were propagated in Eagle's minimal essential medium supplemented with 10% 
fetal calf serum and gentamycin sulfate (0.05 mg per mL). The appropriate sample (0.2 mL) 
was added to the nutrient medium (1 mL) of a confluent monolayer of MARC-145 cells and 
incubated at 37 degrees C in a humid atmosphere of 5% CO:. Cell cultures were examined 
daily for 7 days for cytopathic effect. Culture medium (0.2 mL) from the inoculated wells 
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was used to inoculate a second passage when primary isolation was unsuccessful. Lack of 
cytopathic effect in these cultures was interpreted as a negative test. 
Statistical analysis 
The numbers of infected litters and infected pigs per litter were compared between 
study groups using X2 analysis. Results were considered significant at P<.05. 
Results 
Clinical signs 
CHAL sows 
Mild fevers (1 degrees -3 degrees C above expected normal values) were observed up 
to 4 days postexposure. One sow in the low-dose group had mild icterus from 9-14 DPI and 
aborted at 20 DPI. One sow in the high-dose group aborted at 16 DPI. At postmortem, 
fetuses from one sow in the middle-dose group were not at the proper phase of gestation and 
this sow and litter were eliminated from the study. Ten of 11 litters were composed of a 
mixture of live and dead fetuses; fetuses in one litter in the high-dose group were all alive. 
Dead fetuses comprised a total of 32% of fetuses in the low-dose group, 30% in the middle-
dose group, and 29% in the high-dose group. Autolysis was advanced in approximately 66% 
of the dead fetuses. 
VACC-CHAL gilts 
No clinical signs or pyrexia were noted subsequent to inoculation. One gilt in the 
middle-dose group aborted at 6 DPI; subsequent investigation revealed the cause of abortion 
to be suppurative endometritis, and this gilt and litter were eliminated from the study. One 
gilt in the high-dose group aborted at 21 DPI. One gilt in the middle-dose group had no 
I l l  
fetuses at postmortem. One litter in each of the middle- and high-dose groups had dead 
fetuses, representing 33% and 27% of the fetuses in each litter, respectively. 
Vims isolation 
CHAL sows 
Porcine reproductive and respiratory syndrome virus was isolated from serum of nine 
of 11 sows collected at 7 DPI, and from none of the 11 sows collected at 21 DPI. Virus was 
isolated from at least one sample in 10 of 11 (90.9%) litters (Table 2) and from 58 of 131 
(44.3%) fetuses (Table 3). Of 58 viremic fetuses, 52 were live at necropsy and six were dead 
or autolyzed (Table 3). Viremic fetuses were identified in four low-dose litters (100%), three 
middle-dose litters (100%), and three high-dose litters (75%). The number of viremic fetuses 
in the low-, middle-, and high-dose groups did not differ significantly. Percentages of viremic 
fetuses within affected litters varied from 26.6%-77.7 %. Porcine reproductive and 
respiratory syndrome virus was isolated from lung lavage fluid from eight of 11 sows at 
necropsy (21 DPI). No virus was isolated from control sows or fetuses. 
VACC-CHAL gilts 
No virus was isolated from gilt sera at 7 or 21 DPI, or from any lung lavage fluids 
collected at necropsy. No virus was isolated from fetuses from the low-dose group. Virus was 
isolated from two of 10 litters (one litter in each of the middle- and high-dose groups) and 
from 11 of 116 (9.5%) fetuses (five of 12 [41.7%] and six of 15 [40%] fetuses per litter from 
the middle- and high-dose groups, respectively). All viremic fetuses were live; no dead 
fetuses yielded virus. No virus was isolated from any fetuses in litters without dead fetuses or 
from control gilts or fetuses. 
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Microscopic lesions 
CHAL sows 
Microscopic lesions in exposed sows were limited to mild perivascular 
lymphoplasmacytic infiltration in the uterine submucosa in approximately 66% of sows. No 
significant gross or histologic lesions were observed in control sows or in fetuses from 
exposed or control groups. 
VACC-CHAL gilts 
Minimal uterine submucosal perivascular lymphoplasmacytic infiltrates were 
observed in one gilt in the middle-dose group, while no significant lesions were observed in 
either nonchallenged control group. No significant gross or histologic lesions were observed 
in fetuses. 
Serology 
All animals were seronegative for PRRSV antibody by ELISA test (ELISA S:P ratio 
<0.4) prior to challenge (CHAL sows) or vaccination (VACC-CHAL gilts). All CHAL sows 
had seroconverted by 21 DPI (Table 4). Control CHAL sows remained seronegative 
throughout the study. All VACC-CHAL gilts were seropositive at 0 DPI and had an increase 
in ELISA S:P ratio between 0 DPI and 21 DPI. Control VACC-CHAL gilts (n=2) had similar 
positive ELISA S:P ratios at 0 and 21 DPI. 
Discussion 
The intramuscular challenge exposure route was chosen for this study to assure that 
each animal received the intended specific challenge dose. Reported comparisons of 
intramuscular and intranasal dosing of PRRSV have not demonstrated any significant 
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differences in onset or degree of humoral immune response or infection rate in young 
Pigs"'" 
Although ultrasound examination at day 36 postbreeding indicated pregnancy in one 
VACC-CHAL gilt in the middle-dose group, she was found not pregnant at necropsy. No 
maternal clinical signs or aborted fetal tissues were observed and there were no gross or 
microscopic lesions found at necropsy that would support a diagnosis for the apparent 
resorption of the fetuses. 
Under the conditions of this study, the lowest PRRSV challenge-exposure dose 
resulted in fetal infection and death similar to the higher challenge doses in nonvaccinated 
naïve animals. No significant difference in the percentage of infected litters or in the 
percentage of infected fetuses per litter was identified between different challenge doses in 
the nonvaccinated sows. The infection rate of litters of nonvaccinated sows was significantly 
higher (P<.0005) than that in the vaccinated groups (10 of 11 [90.9%] versus two of 10 
[20%]). Vaccine-induced immunity appeared to protect eight of 10 litters from fetal infection 
under the conditions of this study; however, a significant difference (fc.Ol) in infection 
could be demonstrated only between the low-dose VACC-CHAL and CHAL groups. The 
comparison between VACC-CHAL and CHAL groups did not demonstrate a significant 
difference in litter infection rate in the middle- and high-dose groups; the loss of subject 
females in the middle-dose group had a detrimental effect on the statistical outcome. 
Apparent incompleteness of vaccine-induced protective immunity may be challenge-
dose dependent, in that the low-challenge dose did not produce any infected litters in the 
vaccinated gilts while the middle-challenge dose produced infection in one of two litters, 
while the high-challenge dose produced infection in one of four litters. The percentages of 
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viremic fetuses within these two PRRSV-infected litters were similar to those found in the 
nonvaccinated infected litters, which would be expected since the maternal immune response 
should not affect the progress of an intrauterine infection once the virus has crossed the 
matemal-fetal barrier. 
No virus was isolated from the lung lavage fluid of vaccinated and challenged 
animals, which is consistent with previous experimental reports.4 Microscopic lesions 
identified in the maternal tissues and the lack of lesions in the fetuses are consistent with 
findings of other investigators.12 
In the 13 PRRSV-infected litters, virus was isolated from 64 of 112 (57%) live 
fetuses and from six of 44 (13.6%) dead fetuses (Table 3), which is consistent with previous 
reports.9'1 J'14 This indicates that isolation of virus from dead or autolyzed fetuses is generally 
unrewarding compared to virus isolation from weakbom or stillborn pigs, probably due to the 
instability of the virus in decomposing tissues.4,9,13,14 
Previous studies have demonstrated that PRRSV strain NADC-8 infection will induce 
protection against reinfection with the homologous virus.4,9 Immunity against homologous 
challenge prevented fetal infection for 604 days post initial infection.4 However, protection 
against heterologous strains appears to be less complete and inconsistent,15"18 which is 
consistent with our findings. Collectively, these observations suggest that clinical protection 
may be dependent upon the antigenic similarity between the immunizing and challenge 
viruses. In addition, the present study also suggests that clinical protection induced by field 
viruses against reinfection by heterologous strains may be challenge dose dependent, 
although additional studies are required to confirm this hypothesis. 
115 
These findings, along with information on strain differences and the protection 
provided by homologous challenge,4-9 would suggest that safeguarding the breeding herd 
depends on manipulating a complex interaction based on the antigenic similarity between the 
challenge virus and the vaccine or field virus strains from which herd immunity was 
established, and the challenge dose. In light of these factors, acclimation of breeding stock 
and biosecurity cannot be solely replaced by vaccination programs. 
From a diagnostic standpoint, these findings underscore the need for care in selecting 
samples for laboratory study. In a typical PRRSV-infected litter, the number of noninfected 
fetuses may range from 30%-70%. If samples are collected from only a limited number of 
aborted/weakbom pigs, there is the possibility that only noninfected pigs will be sampled; 
therefore, sample size can be critical when trying to identify PRRSV infection. Because of 
the variable distribution of infected pigs in a litter, samples pooled from multiple weakbom 
pigs submitted for virus isolation are still among the best specimens. Under optimal 
laboratory conditions, tissue or fluids from dead fetuses rarely provide positive virus 
isolations. Considering that the typical specimen submitted to the laboratory is a dead fetus 
from the field, the poor virus isolation rates for PRRSV are not surprising. 
Implications 
• The use of altrenogest in this study constituted an extra-label use for research 
purposes only. We do not advocate the use of this product in commercial swine 
production. 
« Vaccine-induced protection may be incomplete at higher exposure doses. 
• Earlier studies demonstrated long-term solid immunity induced by natural exposure to 
field virus against re-exposure to the homologous virus.4,9 Exposure to heterologous 
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virus as mimicked by this study may provide less reliable protection. Protection of 
breeding swine is likely dependent on the immunological similarity between 
immunizing and challenge strains. 
• Immunization will not replace biosecurity and herd acclimation/stabilization 
practices. 
• Diagnosis of PRRSV-related reproductive disease cannot be reliably achieved by 
sampling dead fetuses. Multiple samples from live- and/or weakbom fetuses are 
required for practical diagnostic attempts. 
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Table 1: Study timeline 
VACC-CHAL gilts Study day CHAL sows 
140 days pre-infcction: 
• gilts allotted to one of four challenge 
dosage groups (control, middle, high) 
• Begin 14-day acclimation period 
0 0 30 days pre-infection: 
• Sows at 60 days of gestation on arrival; 
allotted to one of four challenge dosage 
groups (low, middle, high) 
• Begin 14-day acclimation period 
126 days pre-infection: 
• Draw scrum for ELISA from all 
animals 
• 15 gilts vaccinated with 2cc PRRS 
vaccine 
14 14 16 days pre-infection: 
• Draw scrum for ELISA from all animals 
112 days pre-infection: 
• 2nd IM injection of VACC-CHAL gilts 
with vaccine 
28 30 Begin challenge protocol (day 0): 
• Sows at 90 days gestation, scrum 
sampled, and challenged with appropriate 
dose of PRRSV 
111 -94 days pre-infection: 
• Perform estrus synchronization 
protocol; daily oral administration of 
altrcnoqest 
29-46 37 7 days post-infection: 
• Serum samples collected from females 
93 days pre-infection: 
• One IM injection of eCG/hCG 
47 51 21 days post-infection: 
• Serum samples collected from females 
and fetuses, females necropsicd and fetal 
scrum and tissues and maternal tissues 
are collected 
92 days pre-infection: 
• One IM injection 750 IU hCG 
48 
91 -90 days pre-infection: 
• VACC-CHAL bred by artificial 
insemination 
49-50 Challenge protocol, both groups 
54 days pre-infection: 
• VACC-CHAL gilts at 36 days 
gestation, prcg checked with real-time 
ultrasound 
86 Day 0: 
• Pigs at 90 days gestation, serum sampled, 
and challenged with appropriate dose of 
PRRSV 
Begin challenge protocol (day 0): 
• Gilts at 90 days gestation, serum 
sampled, and challenged with 
appropriate dose of PRRSV 
140 7 days post-infection: 
• Scrum samples collected from females 
7 days post-infection: 
• Serum samples collected from females 
147 21 days post-infection: 
• Serum samples collected from females 
21 days post-infection: 
• Serum samples collected from females 
and fetuses, females necropsicd and 
fetal serum and tissues and maternal 
tissues arc collected 
161 and fetuses, females necropsicd and fetal 
serum and tissues and maternal tissues 
arc collected 
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Table 2: Prevalence of PRRSV-infected litters and fetuses within each group 
Exposure dose group 
Control Low Middle High Total 
CHAL 0/4' 4/4 3/3 3/4 10/11 
0%b 57%(36-78) 51 %(30-64) 43%(27-57) 51 %(27-78) 
VACC- 0/2a 0/4 1/2 1/4 2/10 
CHAL 0%b 0% 42% 40% 41 %(40-42) 
a Number of viremic litters/number in group 
b Average percentage of viremic fetuses within infected litters (range of percentage of 
viremic fetuses within a litter) 
Table 3: Viremic live or dead fetuses per litter 
Group/dose Live, VI+ Live, VI- Dead, VI+ Dead, VI- Total in litter 
7 1 0 2 10 
CHAL low 
7 0 0 2 9 
5 5 0 4 14 
6 1 0 7 14 
6 4 1 0 11 
CHAL middle 5 1 1 3 10 
2 4 1 3 10 
5 1 0 5 11 
CHAL high 
6 2 2 4 14 
0 13 0 0 13 
3 11 1 0 15 
0 9 0 0 9 
VACC-CHAL 0 9 0 0 9 
low 0 9 0 0 9 
0 15 0 0 15 
VACC-CHAL 0 11 0 0 11 
middle 5 3 0 4 12 
6 5 0 4 15 
VACC-CHAL 0 6 0 0 6 
high 0 11 0 0 11 
0 15 0 0 15 
Table 4: ELISA results before and after PRRSV inoculation 
CHAL VACC-CHAL Control VACC-CHAL 
DPI' Mean Range SE Mean Range SE Mean Range SE 
0 <0.4 N/A N/A 0.730 0.511- ±0.05 0.627 0.602- ±0.02 
1.094 9 0.653 55 
21 1.083 0.700- =0.08 2.26 1.925- ±0.06 0.598 0.588- ±0.01 
1.627 1 2.578 7 0.608 4 
1 Day post inoculation N/A=not applicable SE= standard error 
121 
CHAPTER 4. EFFECT OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS INFECTION ON THE OVARY AND PROGESTERONE LEVELS 
IN THIRD TRIMESTER PREGNANT SOWS 
A paper submitted to Theriogenology 
J. E. Benson, M. J. Yaeger, S. P. Ford 
ABSTRACT 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a common cause of 
abortion and reproductive failure in swine. The mechanism of abortion is not fully defined, 
and the effect of the virus on luteal function has not been explored. Late-term pregnant swine 
were exposed to varied doses of PRRSV strain NADC-8. Effects on ovarian function were 
evaluated by serial determination of plasma progesterone levels and by microscopic 
evaluation of ovarian pathologic alterations combined with immunohistochemistry and in situ 
hybridization to detect PRRSV antigen. No specific trend in plasma progesterone level 
associated with PRRSV infection status was identified. Microscopic ovarian lesions were not 
identified and PRRSV antigen was not demonstrated in ovarian tissues by 
immunohistochemistry or in situ hybridization at necropsy 21 days postexposure. Based on 
these findings it does not appear that either a direct or an indirect effect on luteal function 
contributes to PRRSV-induced abortion. 
INTRODUCTION 
Porcine reproductive and respiratory syndrome (PRRS) was first described in 1987 in 
10. 20, 23 
the United States and since has spread worldwide. " The syndrome is caused by an 
22 
encapsulated, single-stranded, positive-sense RNA virus designated PRRSV. Porcine 
reproductive and respiratory syndrome virus is classed in the order Nodovirales, family 
Arteriviridae, genus Arterivirus along with equine arteritis virus (EAV), lactate 
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dehydrogenase elevating virus (LDV), and simian hemorrhagic fever virus (SHF).3 Abortion, 
20 
premature farrowings, and infertility characterize the reproductive syndrome." Piglets born 
19, 20 
live are frequently weak and fail to thrive. Preweaning mortality may approach 80%. 
Although extensive research efforts have greatly increased knowledge of the virus and 
its effects, the exact mechanism of abortion and fetal death has not been determined. 
Although PRRSV has the potential to cross the placental barrier in late gestation (>85 days), 
all fetuses in a litter may not be infected. A typical litter consists of a mixture of normal, 
weakbom, stillborn, and mummified fetuses.14 Generally 30-60% of the litter are affected. " 
Fetuses born viremic and/or premature may survive, and those that die in utero rarely have 
20 
histologic lesions." Pathologic changes in the placenta and uterus similarly have failed to 
account for fetal death. This lack of specific pathologic change has led to speculation that the 
mechanism of abortion may be related to processes that affect the hormonal regulation of 
pregnancy. 
Progesterone secretion from functional corpora lutea is required throughout gestation 
in the pig." Although decreased progesterone levels associated with either direct or indirect 
effects of PRRSV on the ovary could play an important mechanistic role in the induction of 
abortion, investigation of progesterone levels in PRRSV infected pregnant swine has not 
been reported. A drop in progesterone levels has been identified in mares prior to abortion 
induced by EAV, suggesting a possible hormonal mechanism.6 In male swine, PRRSV 
infection of the testicle has resulted in testicular germ cell death, apoptosis and 
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hypospermatogenesis." Similar effects on the ovary could lead to luteolysis and abortion. 
Alternatively, a variety of indirect mechanisms could lead to abortion. Both PRSSV and 
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EAV cause myometrial lesions, and both viruses may cause abortion in the apparent absence 
of fetal infection.6 Release of inflammatory mediators or mediators of apoptosis from a 
uterus with EAV- or PRRSV-induced metritis could affect the corpus luteum. Release of 
inflammatory mediators from infected fetuses could also affect the corpus luteum and lead to 
abortion. 
This study xvas designed to measure serial progesterone levels in late term pregnant 
sows experimentally exposed to PRRSV strain NADC-8, to identify light microscopic visible 
changes in ovarian architecture associated with PRRSV infection, and to identify PRRSV 
antigen and RNA in ovary by immunohistochemistry (IHC) and in situ hybridization (ISH) 
respectively. 
MATERIALS AND METHODS 
Experimental Design 
As part of a related study3, 27 sows were obtained from a herd deemed free of PRRSV 
based on clinical and serologic history. Sows were seronegative for PRRSV by ELISA test 
(HerdChek® PRRS, IDEXX Laboratories, Inc., Westbrook, ME) at purchase and following 
two weeks in climate controlled indoor isolation units. Fourteen sows designated group A 
were naturally mated and pregnant at the time of arrival. Group A animals were randomly 
divided into a PRRSV challenge group and an unexposed control group consisting of 11 and 
3 sows respectively. Thirteen sows designated group B were artificially inseminated in the 
research facility following vaccination for PRRSV; 11 of these sows were challenged with 
PRRSV and 2 served as controls. All challenge females were exposed to PRRSV strain 
NADC-8 at about day 90 of gestation (0 days post inoculation [DPI]) by intramuscular 
injection. Control sows were similarly challenged with a sham inoculum. Blood was 
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collected by jugular venipuncture from each female three times weekly beginning on the day 
of challenge and placed immediately on ice. Plasma was separated within 1 hour of sampling 
and held at -70°C until analyzed for progesterone. 
All animals were euthanized 21 DPI (approximately day 111 of gestation), or at the 
time of earlier spontaneous abortion, and necropsicd. Maternal serum was collected to assess 
for seroconversion to PRRSV. Maternal tissues (cerebrum, cerebellum, pituitary, tonsil, lung, 
liver, kidney, spleen, uterus, ovary, oviduct) were examined for gross and microscopic 
lesions, and ovary was evaluated for PRRSV antigen by ISH and IHC. Fetuses were collected 
from each sow at necropsy. Fetuses were deemed live if they had an umbilical pulse or 
heartbeat. Fetuses identified as dead included autolysed fetuses as well as fresh appearing 
fetuses lacking a heartbeat or umbilical pulse. Fetal serum or thoracic fluid from live or dead 
fetuses respectively was evaluated by virus isolation for PRRSV. 
Challenge Virus 
The NADC-8 PRRSV strain was prepared as previously described.13 Briefly, the virus 
was isolated from the serum of a weak-bom pig cultured on the PRRSV-permissive cell line 
MARC-145 prepared from monkey kidney cells.11 The cell culture was frozen and thawed 
and the virus passed 2 more times. Third passage virus was titrated and diluted with serum-
free minimal essential medium (MEM) to challenge virus inoculums (2 ml volume). A virus-
free control sham inoculum was prepared in a similar fashion from MARC-145 cells. 
Virus Isolation 
Fetal serum or thoracic fluid from live or dead fetuses respectively collected at 
necropsy were evaluated by virus isolation as previously described.15-16 Briefly, cultured 
cells of the MARC-145 cell line cloned from monkey kidney cells were propagated in 
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Eagle's minimal essential medium supplemented with 10% fetal calf serum and gentamicin 
sulfate (0.05 mg/ml). 0.2 ml of the appropriate sample was added to the nutrient medium (I 
ml) of a confluent monolayer of MARC-145 cells and incubated at 37°C in a humid 
atmosphere of 5% CO:. Cell cultures were examined daily for seven days for cytopathic 
effect. Culture medium (0.2 ml) from the inoculated wells was used to inoculate a second 
passage when primary isolation was unsuccessful. Lack of cytopathic effect in these cultures 
was interpreted as a negative test. 
Progesterone Evaluation 
Concentrations of plasma progesterone were quantified by a specific 
radioimmunoassay as previously described and validated in one of the author's laboratories 
(SPF) using the same fully characterized antibody (GDN-337; G. D. Niswender, Colorado 
State University, CO).4 The sensitivity of the assay, as determined by the amount of steroid 
yielding 95% of the counts in the buffer control tube, was 250 pg/ml. The efficiency of the 
extraction, as measured by extraction of labeled hormone, was 77.0 ± 2.7%. The intra- and 
interassay coefficients of variation were 3.0 and 11.3%, respectively. 
Immunohistochemistry 
Immunohistochemical staining of ovarian tissues was performed as previously 
described8 using a modified automated procedure. Briefly, tissues were fixed in 10% neutral 
buffered formalin and routinely processed in an automated tissue processor to paraffin 
blocks. Three-micron thick sections were mounted on poly-l-lysine coated glass slides, 
deparaffmized with 2 changes of xylene and rehydrated through graded alcohol baths to 
distilled water. Endogenous peroxidase was removed by 3% hydrogen peroxide and digestion 
with 0.05% protease. Slides were prepared in an automated immunohistochemical processor 
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utilizing primary monoclonal antibody ascites fluids containing antibodies SDOW-17 and 
SR-30 (Monoclonal antibodies SDOW 17 and SR30 to PRRSV, Rural Technologies, Inc., 
Brookings, SD)17-18 diluted 1:1000 in TRIS/PBS followed by biotinylated goat anti-mouse 
linking antibody, peroxidase-conjugated streptavidin, and 3,3'-diaminobenzidine 
tetrahydrochloride. Slides were counterstained with hematoxylin. 
In Situ Hybridization 
In situ hybridization was performed as previously described.9-14 Briefly, tissues were 
formalinized and processed as for IHC. Three-micron sections were mounted on silanized 
slides, deparaffmized, digested with protease, and acetylated. A hybridization mixture 
prepared by adding lOOpg of the PRRSV RNA probe to 51 pi of hybridization buffer was 
placed on each section and the sections incubated overnight at 52°C. The sections were then 
treated with Rnase A and after rinsing were incubated in 3% blocking solution. Sections were 
then incubated for 2 hours with sheep antidigoxigenin-alkalin phosphate complex diluted in 
1:300 buffer with 3% normal sheep serum. The antidigoxigenin-alkalin phosphate complex 
was removed and a color substrate solution composed of nitro blue tetrazolium with 5-
bromo-4-chloro-indoyl phosphate toluidinium was applied and the sections incubated in the 
dark for 30 minutes. The sections were then counterstained with nuclear fast red. 
RESULTS 
Serology 
All animals were seronegative for PRRSV antibody by ELISA test (ELISA 
serum:positive ratio [S:P ratio] < 0.4) prior to challenge or vaccination. All nonvaccinated 
sows (Group A) seroconverted by 21 DPI (ELISA S:P ratios > 0.4; average 1.083; range 
0.700- 1.627). Control sows remained seronegative throughout the study. All vaccinated 
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animals (Group B) were seropositive at 0 DPI and had an increase in ELISA S:P ratio 
between 0 DPI (average 0.730; range 0.511 - 1.094) and 21 DPI (average 2.26; range 1.925 -
2.578). Control animals had similar positive ELISA S:P ratios at 0 DPI (average 0.627; 
range 0.602 - 0.653) and 21 DPI (average 0.598; range 0.588- 0.608). 
Gross Findings 
Group A: Nonvaccinated animals. One sow had mild icterus from 9 through 14 DPI, 
and aborted at 20 DPI; one sow aborted at 16 DPI. Ten of 11 litters were composed of a 
mixture of live and dead fetuses. Meconium staining indicative of fetal distress was observed 
at least one fetus in all virus-positive litters. 
Group B: Vaccinated animals. One sow aborted 21 DPI. Two litters were composed of 
a mixture of live and dead fetuses. One individual aborted 6DPI due to bacterial endometritis. 
Virus Isolation 
Porcine reproductive and respiratory syndrome virus was isolated from at least 1 fetus 
in 10 of 11 (numbers 1-9 and 11) and 2 of 11 (numbers 6 and 8) litters in groups A and B 
respectively. 
Progesterone Assays 
Results of the assay for progesterone are listed in Table 1 and are graphically 
represented in Figure 1. Levels in test groups paralleled those in the controls. Sows 2 and 8 in 
group A and sow 8 in group B spontaneously aborted and had significantly decreased 
progesterone levels at the time of abortion; however, levels of progesterone were generally 
stable prior to the day of abortion. 
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Histopathologic Evaluation, IHC, and ISH. 
No consistent significant lesions were identified in the ovarian tissues from any of the 
groups on light microscopic examination. No evidence of PRRSV antigen was detected by 
IHC or ISH in ovarian tissues harvested at 21 DPI. 
DISCUSSION 
This study was undertaken, in part, to assess the direct and indirect effects of PRRSV 
on the ovary. Unlike the porcine testicle, in which PRRSV infects germinal cells and 
interstitial macrophages resulting in germ cell depletion and death and hypospermatogenesis 
the ovary showed no evidence of direct effect of PRRSV infection at the time of 
euthanasia based on histologic examination, nor was PRRSV antigen detected in ovarian 
tissue by IHC or ISH in those aborting or euthanized 21 days post PRRSV challenge. 
Significant microscopic differences were not identified in the ovaries of aborting animals 
when compared to uninfected controls. Litters in affected sows were typical of PRRSV-
infected litters, consisting of dead/autolysed and live, weak fetuses. 
In group B, one sow aborted at 6 DPI. Microscopic examination revealed suppurative 
endometritis and placentitis, which were judged unrelated to PRRSV infection. 
In the nonaborting animals euthanized at day 111 of gestation (21 DPI), plasma 
progesterone levels were generally similar to those of uninfected controls. Euthanasia at day 
111 of gestation was selected, in part, to avoid the decrease in progesterone levels normally 
preceding parturition. Plasma progesterone levels in swine begin to drop 48 hours prior to 
normal parturition (around 113 days) and are approximately half the late gestational level 
within 24 hours of parturition.1-7 Spontaneously aborting sows had significantly decreased 
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progesterone levels at the time of abortion. This decrease in progesterone appeared to be 
concurrent with the abortion process and paralleled that reported in normal parturition.7 
It was anticipated that if PRRSV infection affected progesterone secretion, 
progesterone levels would begin to decrease as viral infection progressed, and decrease to 
low levels prior to abortion. Under the conditions of this study such declining values were 
not observed in nonaborting sows prior to euthanasia. Based on these data, it would appear 
that PRRSV has no effect on the ovary or the production of progesterone and that change in 
progesterone level does not contribute to PRRSV-induced abortion. This model did not 
prove ideal for the study of progesterone changes in the immediate prepartum interval, which 
would have required more frequent sampling. However, the objective of the study, to identify 
decreased progesterone levels as PRRSV infection was established and progressed, did not 
require such sampling. Further research would be required to quantitate these changes. 
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Table 1. Plasma progesterone values (pg/ml) of PRRSV vaccinated and 
dpi> 0 7 14 16 18 21 
Litter # Group A 
1 13.41 9.89 10.11 8.37 9.72 ns 
2 15.68 16.28 16.79 13.41 1.85* 
3 15.12 15.98 14.58 14.85 15.03 19.32 
4 17.66 13.SI 14.94 15.59 17.77 25.7 
5 14.15 10.34 22.06 16.38 19.19 20.63 
6 15.59 9.72 20.09 15.21 12.35 12.79 
7 13.41 12.42 15.68 12.21 ns 1.72 
8 22.21 11.93 18.7 1.36* 
9 17.43 17.11 13.9 11.2 11.39 9.51 
10 ns 17.32 ns 22.21 13.98 18.7 
11 ns 15.39 11.43 17.22 11.68 10.25 
Average 16.07 13.65 15.82 14.66 13.89 14.83 
Control 
1 ns 15.39 13.73 16.13 14.2 16.52 
2 ns 17.22 25.98 24.04 22.36 25.02 
3 ns 15.67 18.86 16.91 17.01 20.97 
Average 16.09 19.52 19.02 17.85 20.84 
Group B 
1 15.22 17.22 21.38 18.07 9.46 25.54 
2 13.96 15.48 10.88 15.48 8.56 18.63 
3 29.7 26.58 19.94 15.48 13.88 36.23 
4 22.36 26.18 29.3 22.36 ns 20.84 
5 35.12 22.07 35.43 30.9 34.05 28.54 
6 23.56 13.35 14.53 17.32 13.88 20.71 
7 12.55 2.351 
S 18.29 13.8 11.18 13.65 14.45 5.07* 
9 27.94 26.61 29.46 37.39 26.43 19.43 
10 16.71 10.88 ns 23.41 14.7 11.37 
11 3R.73 23.1 19.94 21.59 15.39 18.18 
Average 23.1 19.5 21.34 21.56 16.75 22.16 
Control 
1 19.69 16.52 19.69 14.04 15.57 16.04 
t 11.43 14.12 16.04 17.43 14.28 24.27 
Average 15.56 15.32 17.86 15.74 14.92 20.16 
ns= not sampled " = day of abortion; values not included in averages 
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Figure 1. Average plasma progesterone levels ± standard error, pg/ml 
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CHAPTER 5. A COMPARISON OF VIRUS ISOLATION, IMMUNOHISTOCHEMISTRY, 
FETAL SEROLOGY, AND REVERSE TRANSCRIPTION POLYMERASE CHAIN 
REACTION FOR THE IDENTIFICATION OF PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS TRANSPLACENTAL INFECTION 
IN THE FETUS 
A paper submitted to The Journal of Veterinary Diagnostic Investigation 
James E. Benson, Michael J. Yaeger, Jane Christopher-Hennings, 
Kelly Lager, Kyoung-Jin Yoon 
Abstract 
Virus isolation (VI), immunohistochemistry (IHC), fetal serology, and reverse-
transcription polymerase chain reaction (RT-PCR) were performed on samples from 107 
fetuses comprising 10 litters taken from sows experimentally infected with porcine 
reproductive and respiratory syndrome virus. In addition to comparing the relative 
sensitivity and specificity of each test, RT-PCR was evaluated with respect to the relative 
suitability of thoracic fluids and tissues as samples, the effects of autolysis, and the effects of 
pooling of fetal specimens. VI, IHC, and fetal serology identified PRRSV infection in 48.6, 
23.4, and 14.9% of 107 fetuses respectively, and identified at least one infected fetus in 10, 
10, and 5 of 10 litters respectively. In-utero death with autolysis reduced the test efficacy of 
all three methods. Fetal thoracic fluid and tissues proved equally suitable for RT-PCR 
detection of PRRSV. Pooling fetal tissues or fluids from VI-positive animals with 
comparable material from negative controls had no detrimental effect on RT-PCR results 
when evaluated at dilutions of 1:1, 1:2, 1:4, and 1:8. The results of RT-PCR testing were 
positive in 100, 94.4, and 83.3% of VI-positive specimens allowed to autolyze at 4, 21 or 
37°C respectively for 24, 48, and 96 hours. Compared to the other testing modalities, RT-
PCR appeared to be impacted the least by the adverse effects of autolysis. 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major cause of 
reproductive failure in swine characterized by late term abortion and the birth of a mixture of 
weak-bom and stillborn pigs and dead autolyzed fetuses.17 Porcine reproductive and 
respiratory syndrome (PRRS) can be difficult to diagnose because fetuses are the most 
common specimen submitted to diagnostic laboratories in abortion cases, and there are no 
consistent gross or microscopic lesions in fetuses.17 Development of practical techniques for 
assessing the PRRSV status of fetuses would greatly improve the ability of diagnosticians to 
identify PRRSV-induced abortion and allow producers and veterinarians to more efficiently 
manage reproductive losses. 
Although PRRSV can be readily isolated from the serum or tissues of presuckled, 
congenitally infected piglets, in utero autolysis rapidly inactivates the virus and interferes 
with isolation from aborted transplacental^ infected fetuses.12-21 Consequently, virus 
isolation (VI) for PRRSV on fetuses submitted from field cases of abortion has been 
extremely disappointing. Other potential techniques for the diagnosis of transplacental 
PRRSV infection include immunohistochemistry (IHC), fetal serology, and the reverse 
transcription polymerase chain reaction (RT-PCR). Immunohistochemical techniques have 
been used extensively to identify PRRSV antigen in numerous tissues.9-10 Fetal serology has 
been attempted in a variety of abortion diseases, albeit with mixed results.1-3-8- "•13-1S-19-22 
Because PRRSV typically causes late gestation reproductive failure, there is the potential for 
aborted or stillborn fetuses to develop a detectable immune response. Reverse transcription 
polymerase chain reaction tests have been described for the detection of PRRSV nucleic 
acids in serum and tissues.6-7-20 Because successful application of RT-PCR techniques relies 
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on the presence of genetic material rather than infectious virus, RT-PCR can be used to 
detect inactivated or incomplete virions. In addition, the amplification properties of RT-
PCR allow detection of very low concentrations of the target material. 
This study compares the use of VI, fetal serology, IHC, and RT-PCR techniques for 
the detection of transplacental PRRSV infection in fetuses derived from sows experimentally 
infected with PRRSV during late gestation. In addition, this study evaluates the effect of 
fetal autolysis and pooling of tissues and serum or thoracic fluids from multiple fetuses on 
RT-PCR, and the relative suitability of thoracic fluids and tissues for RT-PCR. 
Materials and methods 
Experimental animals. As part of a related study-, naturally mated pregnant sows 
were obtained from a herd deemed free of PRRSV based on clinical and serological history. 
Sows were seronegative for PRRSV at purchase and following two weeks in isolation. Ten 
randomly selected females were exposed to PRRSV on or about day 90 of gestation by 
intramuscular injection of PRRSV strain NADC-8. Similar sows challenged with a sham 
inoculum served as controls. All animals were euthanized 21 days post inoculation (DPI) 
(approximately day 111 of gestation) and necropsicd. Serum was collected to assess for 
seroconversion in exposed animals. Fetuses were collected from each sow at necropsy. 
Fetuses were deemed live if they had an umbilical pulse or heartbeat. Fetuses identified as 
dead included autolysed fetuses as well as fresh appearing fetuses lacking a heartbeat or 
umbilical pulse. Serum or thoracic fluid from live or dead fetuses respectively and tissues 
(brain, lung, cardiac muscle, liver, spleen, tonsil, placenta, umbilical cord, aorta, thymus, and 
mediastinal lymph nodes) were collected from each fetus and held at -70°C pending testing. 
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Similar tissues were routinely fixed in 10% neutral buffered formalin. Fetal specimens from 
sham-challenged sows served as laboratory test controls. 
Challenge virus. The NADC-8 PRRSV strain was prepared as previously 
described.13 Briefly, the virus was isolated from serum of a weak-born pig on MARC-145 
cells. The cell culture was frozen and thawed and the virus passed 2 more times. Third 
passage virus was titrated and diluted with serum-free MEM to prepare challenge virus 
inoculums. A virus-free control sham inoculum was prepared in a similar fashion from 
MARC-145 cells. 
Virus isolation. Virus isolation on fetal sera or thoracic fluid was performed as 
previously described.13-15 Briefly, cultured cells of the MARC-145 cell line were propagated 
in Eagle's minimal essential medium supplemented with 10% fetal calf serum and 
gentamycin sulfate (0.05 mg/ml). Two hundred microliters of the appropriate sample was 
added to the nutrient medium (1 ml) of a confluent monolayer of MARC-145 cells and 
incubated at 37°C in a humid atmosphere of 5% CO:- Cell cultures were examined daily for 
seven days for cytopathic effect. Culture medium (0.2 ml) from the inoculated wells was 
used to inoculate a second passage when primary isolation was unsuccessful. Lack of 
cytopathic effect in these cultures was interpreted as a negative test. 
Fetal serology. Samples of fetal serum or thoracic fluid from live or dead fetuses 
respectively were tested for PRRSV antibodies by indirect fluorescent antibody test as 
previously described.23 Briefly, MARC-145 cells were propagated and seeded onto 8-
chamber slides. Cell cultures were incubated in Eagle's minimal essential medium with 10% 
fetal bovine serum plus 0.25 pg/ml amphotericin-B and 50 pg/ml gentamicin in a humidified 
chamber at 37°C supplemented with 5% CO" until 70-80% monolayered (about 34 hours). 
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Strain NADC-8 PRRSV-infected culture medium containing sufficient virus to produce 15-
20 plaque forming units was added to each chamber and the cultures incubated for 24-36 
hours. Culture medium was removed and the monolayers were fixed in 80% aqueous acetone 
for 10 min. and stored at -80°C until used. Serum samples were diluted 1:20 in PBS; 50 pi of 
diluted serum was placed in each chamber and the slides were incubated for 30-45 min. at 
37°C. Slides were washed with successive changes of PBS followed by distilled water. Slides 
were coated with 50 pi goat anti-swine IgG conjugated with fluorescein isothiocyanate, 
incubated 30-45 min., and examined by fluorescent microscopy. Test monolayers were 
compared with negative and positive controls; positive status was based on the presence of 
typical foci of fluorescence. 
Immunohistochemistry. Immunohistochemical staining of fetal lung, thymus, liver, 
spleen, and umbilical cord was performed as previously described 9 using a modified 
automated procedure. Briefly, tissues were fixed in 10% neutral buffered formalin and 
routinely processed in an automated tissue processor to paraffin blocks. Three-micron thick 
sections were mounted on poly-l-lysine coated glass slides, deparaffmized with 2 changes of 
xylene and rehydrated through graded alchohol baths to distilled water. Endogenous 
peroxidase was removed by 3% hydrogen peroxide and digestion with 0.05% protease. Slides 
were prepared in an automated immunohistochemical processor utilyzing primary 
monoclonal antibody ascites fluids containing antibodies SDOW-171 and SR-30a diluted 
1:1000 in TRIS-phosphate buffered saline followed by biotinylated goat anti-mouse linking 
antibody, peroxidase-conjugated streptavidin, and 3,3 '-diaminobenzidine tetrahydrochloride. 
Slides were counterstained with hematoxylin. 
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RT-PCR. Individual fetuses. Pooled tissue samples (lung, liver, brain, spleen, 
umbilical cord) from each fetus were placed in a separate sterile whirl pak bag. Two mis of 
sterile Hanks' buffer per gram of fetal tissue composite was added and the tissues were 
homogenized for 120 seconds in a stomacher. One ml of the resulting homogenate was 
drawn off with a separate, sterile pipet and held at -70°C until tested by RT-PCR as described 
below. 
Effect of pooling. Pooled tissue homogenate prepared as above and thoracic fluid 
from each of six VI/RT-PCR positive fetuses were pooled with similarly processed tissue 
homogenate or thoracic fluid from VI/RT-PCR negative control fetuses at dilution ratios of 
1:1, 1:2, 1:4, and 1:8 and the resulting pooled specimens tested by RT-PCR as described 
below. 
Effect of fetal autolysis. Pooled tissues (brain, liver, spleen, lung, umbilical cord) 
from 9 PRRSV VI-positive fetuses were divided evenly into four aliquots on individual 
weighing boats with a separate sterile scalpel blade under a laminar flow hood, placed in 
separate whirl pak bags, and incubated for 0, 24, 48, or 96 hours to mimic postmortem 
decomposition. Groups A, B, and C, each consisting of samples from 3 fetuses, were stored 
at 4°C, 21°C, and 37°C respectively. After incubation 1 ml of free tissue fluid was drawn off 
each sample with a separate, sterile pipet to mimic thoracic fluid. Gloves were changed 
between samples. Samples incubated at 37°C were processed first as these samples were the 
most likely to be negative. Two ml of sterile Hanks' buffer per gram of fetal tissue was added 
to the remaining tissue and the tissues homogenized for 120 seconds. One ml of tissue 
homogenate from each sample was drawn off with a separate, sterile pipet. Each of the 
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resulting 63 tissue homogenate and thoracic fluid samples was held at -70°C until tested by 
PGR as described below. 
Comparison of tissue RT-PCR and thoracic fluid RT-PCR. Thoracic fluid from 20 
fetuses that were tissue homogenate VI/RT-PCR positive and 9 fetuses that were VI/RT-PCR 
negative were assessed and the tissue and fluid results compared. 
RT-PCR procedure. Samples of tissue and fetal fluids were analyzed by RT-PCR 
technique as previously described.5-6 Sterile gloves were worn routinely throughout the 
procedures and repeatedly changed as appropriate. Tissue samples were homogenized in 2 ml 
Hank's balanced salt solution per gram of tissue. Five hundred microliters of serum, thoracic 
fluid, or tissue homogenate was added to an equal volume of lysis buffer consisting of 4M 
guanidinium thiocyanate, 25 mM sodium citrate (pH 7), 0.5% sarcosyl, and 0.1 M 2-
mercaptoethanol. Five hundred microliters of the lysed product was then added to an equal 
volume of phenol chloroform-isoamyt alchohol, vortexed, and centrifuged at 10,000x g for 5 
min. Extraction with phenol chloroform-isoamyl alchohol was repeated and the upper phase 
transferred to 500 pi chloroform-isoamyl alchohol and centrifuged. One-third volume of 2 
M sodium acetate (pH 4) and 2 volumes cold 95% ethanol were added to the sample and then 
frozen at -70 C for 1 hour. The sample was centrifuged at 16000 x g washed twice in 70 % 
ethanol, and resuspended in 30 pi sterile distilled water.b The sample was held at -70°C. 
Outer and nested primers were derived from ORF 7 of the PRRSV strain VR-2332 
genome. The outer sense and antisense primers were nucleotides 2763-2785 (5'-
TCGTGTTGGGTGGCAGAAAAGC-3') and nucleotides 3247-3225 (5'-
GCCATTCACCACACATTCTTCC-3'), respectively. The nested sense and antisense 
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primers were nucleotides 2885-2907 (5'-CCAGATGCTGGGTAAGATCATC-3') and 
nucleotides 3121-3099 (5'-CAGTGTAACTTATCCTCCTGA-3'), respectively. 
A commercially available RT-PCR system0 was utilized for reverse transcription and 
outer and nested RT-PCR reactions. The outer and nested reactions consisted of 40 and 30 
cycles respectively. Denaturing, annealing, and extension temperatures and times were 95° C 
for 25 seconds, 58° C for 5 sec, and 74° C for 25 seconds respectively. A 484-bp outer and 
236-bp nested product were visualized on a 1% agarose geld containig 0.5 pg ethidium 
bromide/ ml of agarose. The gel was subsequently photographed under UV illumination. This 
RT-PCR assay could detect as few as 10 virions/ml.6 
Results 
Clinical observations. All exposed females seroconverted by 21 DPI. A total of 107 
fetuses from 10 litters were evaluated for evidence of PRRSV infection by VI, IHC, and fetal 
serology. Tissues from 94 of these fetuses were also evaluated by RT-PCR. Of the 107 total, 
34 (31.8%) were dead and 73 (68.2%) were deemed alive at the time of necropsy 21 DPI. 
Results are tabulated in Table 1 (data from fetuses negative by VI, IHC, and fetal serology 
not shown). Specimens from 50 fetuses derived from 4 control litters were negative by all 
methods. 
Virus isolation. Fifty-two of 107 fetuses (48.6%) were positive by VI. Four of 34 
dead fetuses (11.8%) were VI positive, while 48 of 73 live fetuses (65.7%) were positive. Of 
the 52 VI positives, 48 (92.3%) were deemed alive at the time of sow necropsy. Virus 
isolation identified at least one positive fetus in each litter. 
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IHC. Twenty-five of 107 fetuses (23.4%) were positive by IHC. Thymus, liver, 
spleen, lung, and umbilical cord were positive in 25, 16, 15, 8 and 5 specimens respectively. 
Thymus was the only tissue to be positive in all IHC-positive fetuses. All of the 25 IHC-
positive fetuses were identified as positive by VI. Twenty-four of 25 IHC positive fetuses 
(96%) were deemed alive at the time of sow necropsy. All litters had at least one IHC 
positive fetus. The sensitivity of IHC as compared to VI was 48.1 and 100% on a per fetus 
and per litter basis respectively when all five tissues were assessed. Specificity as compared 
to virus isolation was 100%. 
Fetal serology. Sixteen of 107 (14.9%) fetuses were positive by fetal serology. All 16 
were positive by VI; only 3 were positive by IHC. Fifteen of 16 (93.8%) were alive at sow 
necropsy. Five of 10 (50%) litters had at least one serologically positive fetus. The sensitivity 
of fetal serology as compared to VI was 30.8 and 50% on a per fetus and per litter basis 
respectively. Specificity as compared to virus isolation was 100%. 
RT-PCR Individual samples. Of the 94 samples evaluated, 88 (93.6%) were RT-
PCR positive. Fourty-seven samples were VI/RT-PCR positive, 4 samples were VI positive/ 
RT-PCR negative, 41 samples were RT-PCR positive/ VI negative, and 2 samples were 
VI/RT-PCR negative. Of the samples that were RT-PCR positive and VI negative, 28 
(68.3%) came from pigs that were dead in utero. 
Pooled samples. Forty-eight samples were tested, representing six VI/RT-PCR 
positive tissue homogenates and six VI/RT-PCR positive thoracic fluids each diluted at 1:1, 
1:2, 1:4, and 1:8 with similar specimens from negative control animals that were VI/RT-
PCR-negative. All 48 pooled samples were positive by RT-PCR. 
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Autolyzed samples. All tissue and thoracic fluid samples from VI positive fetuses 
were RT-PCR positive at time 0 and at each postincubation time period with the exception of 
2 tissue samples (21°C/48 hrs and 37°C/48hrs) and two thoracic fluid samples (37°C /24 
and48 hrs) (Table 2). Of 54 incubated samples, 50 (92.6%) were positive. Samples held at 
typical refrigerator temperature (4°C , group A), room temperature (21°C , group B), and at 
normal body temperature (37°C, group C) remained positive in 18 of 18 ( 100%), 17 of 18 
(94.4%), and 15 of 18 (83.3%) samples respectively. 
Comparison of tissue RT-PCR and thoracic fluid RT-PCR. All 20 thoracic fluid 
samples from tissue homogenate VI/RT-PCR-positive fetuses were RT-PCR positive. All 9 
thoracic fluid samples from tissue homogenate VI/RT-PCR-negative fetuses were negative. 
If the 27 pairs of samples from the autolysis study are included, RT-PCR on tissue and 
thoracic fluid were in agreement on 43 of the 47 (91%) sets of samples. In two cases in the 
autolysis study tissue pools were positive while the thoracic fluid was negative and in two 
cases thoracic fluid was positive and tissue pools were negative. 
Discussion 
The sensitivity and specificity of diagnostic tests are generally based on a "gold 
standard." Unfortunately, there is currently no recognized gold standard for the detection of 
PRRSV in transplacental^ infected fetuses. In live pigs, swine bioassay may be the most 
sensitive test for the detection of PRRSV. However, this standard may not be applicable to 
aborted fetuses because of the complications of in utero death and fetal autolysis. For the 
purposes of this comparison, VI will be the standard against which the other tests are 
evaluated. 
145 
It was anticipated that fetal serology would detect a large percentage of PRRSV-
infected fetuses as sows were inoculated when fetuses were immunocompetent and the 
majority of fetuses were collected 21 days DPI. Antibody has been demonstrated in fetal 
serum under similar experimental circumstances.13 The IF A test was chosen in this trial to 
allow use of the challenge virus as the cell culture inoculum. The IF A tests to detect IgG 
specific for PRRSV antigen were positive in only 14.9% of fetuses. The IFA tests were quite 
specific as titers were only detected in VI-positive fetuses. However, fetal serology only 
detected 16 (30.8%) of 52 VI positive fetuses, and one or more IFA-positive fetuses were 
detected in only 5 of 10 (50%) infected litters. Even if the entire litter is evaluated, fetal 
serology appears to be of limited value. In this experimental model, fetal samples were 
collected 21 DPI; in field cases utilizing full-term weakbom, presuckled piglets, the duration 
of intrauterine exposure may be longer, resulting in a higher percentage of positive animals. 
Application of serologic testing could be enhanced by the use of an IgM rather than an IgG 
based test, as IgM levels rise before IgG; this would be fertile ground for further research 
Immunohistochemistry proved to be more sensitive than fetal serology under the 
conditions of this study. When thymus, liver, spleen, lung and umbilicus from each fetus 
were assessed on a single IHC slide, PRRSV antigen was detected in one or more tissues of 
25 fetuses. Overall, IHC detected PRRSV in 23.4% of fetuses and 48.1% of VI positive 
animals. IHC detected PRRSV antigen in at least one fetus in all VI-positive litters. In 
fetuses in which PRRSV antigen was detected in one or more tissues, positive cells were 
identified in 100% of the thymuses, 64% of livers, 60% of spleens, 32% of lungs and 20% of 
the umbilical cords. These results indicate that tissue selection may have a dramatic impact 
on the sensitivity of PRRSV IHC. However, these results might not be relevant to all strains 
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of PRRSV. In a report involving a limited number (13) of naturally infected fetuses, IHC 
demonstrated PRRSV in fetal spleen, lung and liver, and thymus in 7, 5, and 4 fetuses 
respectively.4 
This study emphasizes the potential impact of autolysis on the detection of PRRSV 
in fetuses. The adverse effect of autolysis on VI has been well documented.'--21 Of the 107 
fetuses evaluated, 34 (31.8%) were dead and 73 (68.2%) were alive at the time of sow 
necropsy. Four of the dead fetuses (11.8%) were VI positive, while 48 of the live fetuses 
(65.7%) were positive. Of the 52 VI-positive fetuses, 48 (92.3%) were alive at the time of 
necropsy 21 DPI. These results are in agreement with other studies that indicate in PRRSV-
positive tissues stored at 25°C, virus isolation rates decreased to 47% and 7% at 24 and 72 
hours respectively.-' Similarly stored serum was less affected in that study. 
Fifteen of 16 (93.8%) serologically positive fetuses were alive at the time of sow 
necropsy. Autolysis has been observed to negatively influence fetal serology in other 
abortion related diseases.16 However, considering the dynamics of fetal infection and 
immune response, there is a strong possibility that the dead fetuses died prior to the 
development of an immune response. 
Perhaps the most intriguing finding of this study is the limited impact of autolysis on 
PRRSV RT-PCR. Autolysis had a limited impact even at in utero temperatures, and minimal 
impact under typical refrigeration and room temperatures. The decrease in sensitivity of RT-
PCR under conditions of autolysis compares favorably to the more severe decrease in VI 
rates under similar conditions.-' As such, it appears that RT-PCR would be a valuable 
diagnostic tool even utilizing the autolyzed specimens routinely submitted to diagnostic 
laboratories. 
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Pooling of 1 positive tissue or thoracic fluid sample with up to 8 negative similar 
samples did not influence the ability to detect PRRSV with RT-PCR This magnitude of 
dilution mimics that which would result from pooling specimens from all fetuses within a 
litter. In addition, both tissue and thoracic fluids gave similar results when tested by RT-
PCR. These results suggest that RT-PCR testing of carefully collected field samples of 
thoracic fluid or fetal serum from presuckled piglets or stillborn fetuses would be a practical 
approach to diagnosis. Pooling of such samples from multiple fetuses will decrease the 
possibility of missing infected specimens, and will reduce laboratory cost and labor. 
A high percentage of individual fetuses were positive by RT-PCR. Three possibilities 
should be considered for these results. All fetuses were from sows challenged with PRRSV. 
As such, it is conceivablc that all RT-PCR-positive fetuses were infected with the virus. This 
study demonstrated the negative impact of autolysis on VI and the limited impact of autolysis 
on RT-PCR. It is interesting to note that in 68% of the fetuses that were VI-/ RT-PCR+ were 
dead in utero. Based on these findings, one may speculate that in autolyzed specimens, RT-
PCR was indeed more sensitive than VI. Reports describe similar findings in naturally 
infected fetuses.4 However, the authors concede that the final possibility for the high 
numbers of RT-PCR-positive fetuses may have been a function of cross contamination 
between fetuses at postmortem. It appears that the procedures to minimize cross 
contamination were sufficient between sows, as all samples from negative control animals 
remained negative. But considering the sensitivity of RT-PCR and the facilities available for 
necropsy, the possibility of cross contamination of fetuses within a litter does exist, and these 
results should be interpreted with caution. 
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Sources and manufacturers 
a Rural Technologies, Inc., Brookings, SD 
b Gibco BRL, Grand Island, NY. 
c GeneAmp RT/PCR kit, Applied Biosystems, Foster City, CA. 
d SeaKem, FMC Bioproducts, Rockland, MA 
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Table 1. Results of virus isolation (VI), immunohistochemistry (IHC), fetal serology, and 
reverse transcription polymerase chain reaction (RT-PCR) testing of fetuses from porcine 
reproductive and respiratory syndrome virus (PRRSV) infected sows. Fetuses with all 
negative values for VI, IHC, and serology not shown. 
Sow # Pig## Live/dead VI IHC positive tissue1 Serology RT-PCR 
10 1 1 POS thy neg POS 
10 2 1 POS sp.thy.li neg POS 
10 3 1 POS neg neg neg 
10 4 1 POS neg neg POS 
10 6 1 POS neg neg POS 
11 12 1 POS spl.thy.li.lu neg NT" 
12 2 1 POS spl.thy.li neg POS 
12 5 1 POS spl.thy neg POS 
12 6 1 POS neg POS POS 
12 7 1 POS neg POS POS 
12 S I POS neg POS POS 
12 9 1 POS neg POS POS 
12 10 1 POS neg POS POS 
14 1 1 POS spl.thy.li.lu neg POS 
14 2 1 POS spl.thy.li.lu neg POS 
14 3 POS spl.thy.li.lu.umb neg POS 
14 5 1 POS spl.thy.li.lu neg POS 
14 7 1 POS neg neg neg 
14 S 1 POS neg neg POS 
14 9 1 POS neg neg POS 
15 1 1 POS neg nee neg 
15 4 POS neg POS POS 
15 7 1 POS neg POS POS 
15 S 1 POS neg POS POS 
15 9 1 POS neg POS POS 
15 10 1 POS thv.lu.umb POS POS 
16 1 1 POS thy neu POS 
16 2 1 POS spl.thy.li,umb POS POS 
16 3 1 POS neg POS POS 
16 4 1 POS thy.li neg POS 
16 5 1 POS spl.thy.li.lu neg POS 
16 6 1 POS spl.thy.li.lu.umb neg POS 
16 7 1 POS neg neg POS 
17 2 1 POS thy.li neg POS 
17 3 D POS neg neg POS 
17 4 I POS thy.li neg POS 
IS 2 1 POS spl.thy.li,umb POS POS 
IS 3 1 POS spl.thy.li neg POS 
IS 4 D POS neg neg POS 
IS S 1 POS thy neg POS 
IS 10 1 POS neg POS POS 
IS II 1 POS neg POS POS 
IS 12 1 POS thv neg POS 
19 S 1 POS neg POS neg 
19 10 1 POS thy neg POS 
19 12 I POS spl.thy neg POS 
19 13 1 POS neg neg POS 
20 1 1 POS neg neg POS 
20 2 1 POS neg neg POS 
20 5 1 POS thy neg POS 
20 S 1 POS neg neg POS 
20 9 1 POS spl.thy.li nee POS 
'thy=thymus; li=liver: lu=lung; spl=spleen; umb=umbilical cord ^NT = not tested 
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Table 2. Results of reverse transcription polymerase chain reaction (RT-PCR) 
analysis of porcine reproductive and respiratory syndrome virus (PRRSV) RT-PCR-
positive tissue and thoracic fluid samples following autolysis at various temperatures. 
Sample Temp °C 
Tissue Thoracic 
fluid 
24hrs 48hrs 96hrs 24hrs 48hrs 96hrs 
A 4 POS POS POS POS POS POS 
B 4 POS POS POS POS POS POS 
C 4 POS POS POS POS POS POS 
D 21 POS neg POS POS POS POS 
E 21 POS POS POS POS POS POS 
F 21 POS POS POS POS POS POS 
G 37 POS neg POS POS POS POS 
H 37 POS POS POS neg POS POS 
I 37 POS POS POS POS POS neg 
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CHAPTER 6. GENERAL CONCLUSIONS 
It has been said that good research and good researchers not only answer questions 
but also identify new and continued directions for further study. The research reported in 
this dissertation successfully fulfills those goals. Certainly there is much yet to be learned 
about the pathogenesis, control and diagnosis of PRRS. 
The Effects of Exposure Dose 
In this study, groups of four sows each were inoculated with titered exposure doses of 
virulent PRRS virus. In naïve, unvaccinated sows, all dose groups were successfully 
infected, indicating that the smallest dose administered in this trial was adequate to initiate 
infection. The trial was not designed to identify a minimum infectious dose for sows and the 
lowest dose used should not be so construed. It was not anticipated that one sow in the high 
dose group would be the only individual to remain uninfected. No specific cause for this was 
determined, beyond the vagaries of Sus scrofa and failure of individuals of that species to 
react as expected. Unfortunately, there was a loss of individuals in the middle dose groups in 
both vaccinated and unvaccinated animals. Reduction of the middle dose vaccinated group 
to 2 individuals casts doubt on any conclusions that may be drawn. 
Among vaccinated groups, there was considerably more variability in infection rate. 
Apparent vaccine-induced protection was adequate to protect all exposed individuals in the 
low dose group only. Protection in the middle and high dose groups was less complete, 
giving support to the thesis that exposure dose can overcome vaccine induced protection. 
Statistical significance between infection rates could only be assigned between the 2 low 
dose groups, however, due to 1 ) the loss of individuals from the middle dose groups and 2) 
the failure of one of four nonvaccinated high dose individuals to be come infected. Were 
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resources no concern, doubling the size of each group would have been a propitious decision; 
in the real world, however, one must deal with limitations on group size in large, costly, and 
expensively housed subjects, and live with the results. 
There remain questions concerning vaccine protection that could be experimentally 
addressed were there adequate resources for study. Ideally, both modified-live and killed 
virus vaccines prepared from different virus strains should be tested by challenge of 
vaccinated sows to field strains with varied genetic relationship to the vaccine virus. 
Comparison should be made to the protection resulting from previous exposure to field virus 
as well, and again use of genetically different challenge strains would be in order. Such 
studies would require a significant numbers of subjects. It is tempting to perform such 
studies on smaller, less costly and more easily handled pigs and attempt extrapolation of 
protection against respiratory disease to that against reproductive disease, but the variation in 
infectivity and possible variations in tropism of various strains of PRRSV makes such an 
attempt untenable.1-4"6-l0-14 
While one is busy spending money, it would also be of value to perform similar 
vaccination and exposure regimens in boars and evaluate the ability of vaccines or previous 
exposure to protect against infection, semen shedding of virus, and induction of apoptosis 
with divergent strains of field virus. Some studies of this type using a single challenge strain 
have been done.--13 
Considering the results of this study and field experience, it is tempting to speculate 
that exposure dose and the degree of relative homology of the vaccine and challenge strains 
form an inverse, linear relationship. A high degree of homology would require relatively 
massive exposures to induce abortion, while challenge with a field strain widely divergent 
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from the vaccine strain would require a relatively minimal exposure, approximating exposure 
of a naïve individual. 
A further area of study would be the relative degree of protection afforded by 
injectable vaccine as opposed to oral or intranasally administered modified live virus 
vaccine. Oral vaccine against transmissible gastroenteritis in swine and intranasal vaccine 
against infectious bovine rhinotracheitis have been used to good advantage in the past.3-7-8-
11.12,15, is These vaccines are more effective at stimulating IgA secretory antibody and 
provide a higher level of protection at the tissue entry level. 
Effects of PRRSV on Ovarian Function 
No evidence of a diminution in progesterone levels associated with PRRSV infection 
was identified in this study. There are, however, several points that can be made concerning 
the procedures used. Progesterone levels declined rapidly in the last 24 to 48 hours 
preceding abortion in spontaneously aborting individuals. The sampling method employed in 
this study was inadequate to allow complete evaluation of the character and rate of this 
decline. Ideally, samples should be taken frequently enough to allow elucidation of rapid 
changes, perhaps as often as 4 to 6 times per 24 hour period. In practical terms, this would 
require cannualization of a vessel to allow noninvasive repeated collections. Because 
abortion occurs with little prodromal sign, all individuals in a study would need to be 
sampled for a number of days prior to anticipated abortion; an appropriate plan may be to 
expose sows to field virus and begin frequent serial sampling on the 7th postexposure day. 
To insure adequate numbers of aborting individuals for meaningful statistical analysis- say 
20 aborting sows- one would need to inoculate some 100 or more sows, assuming that the 
abortion rates would be similar to that experienced in this study. If sows abort up to 20 days 
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postexposure, some 8000+ samples could be generated. To be accurate, each of these sows 
should be artificially mated to insure exact knowledge of gestational stage; to produce 100 
bred sows by AI would likely require beginning with 120 or so. The enormity of this task 
would soon cool the ardor of the most enthusiastic researcher. Be that as it may, the results 
of this study give at least preliminary evidence that PRRSV does not affect progesterone 
levels, and do not lend strong support for further investigation. 
Although PRRSV has been shown to exert effects on the testes17, no evidence of 
change was discernable in ovarian tissues on light microscopic examination, and no PRRSV 
was detected by IHC or ISH at 21 DPI. Although no evidence of apoptosis was identified on 
light microscopy, it may have been of value to perform TUNEL staining of ovarian tissues to 
identify any early apoptotic change. 
While no direct evidence of endocrine effects was identified, other factors may be 
worthy of investigation. Inflammatory mediators induced by PRRSV in the uterine 
microcirculation may induce a local or paracrine effect on the placenta. Such a paracrine 
effect may allow one fetus to be affected independent of another, and result in the typical 
mixed bag of effects seen in PRRS litters. 
Comparison of PRRSV Diagnostic Methods 
Not surprisingly, rtPCR proved highly sensitive in identification of transplacental^ 
infected fetuses. Obviously, using appropriate procedures to insure that cross-contamination 
between fetuses could not occur would have a significant improvement in confidence in the 
results of individual fetus testing. 
In addition to sensitivity, rtPCR was also shown to be relatively more resistant to 
postmortem degradation than VI. This would be expected to be of value in field cases where 
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postmortem in utero decomposition is complicated by delay in sampling during shipment to 
diagnostic centers. One of the factors which makes rtPCR applicable to fetal investigation is 
that the fetus can be submitted in its entirety, precluding contamination with PRRSV RNA 
from the environment of the farm or veterinarian's facility. This does not, of course, 
eliminate the necessity for appropriate procedures to avoid contamination at the diagnostic 
laboratory. This possibility for contamination is a negative factor in PGR testing of 
laboratory specimens in general, and will be a challenge to the interpretive skills of both 
laboratory diagnostician and practitioner as PGR testing becomes more common. A positive 
rtPCR result from a properly handled fetus would, however, give strong support to a 
diagnosis of PRRS where clinical findings are supportive. It will be interesting to follow 
results of routine case testing within laboratories to observe the relative reliability of these 
test modalities. 
Immunohistochemistry was moderately successful in identifying infected tissues. 
The frequency of positive staining in thymus was relatively higher in this trial than has been 
reported in a similar limited investigation of field virus infected specimens.1 Again, this 
variance may be attributable to varying tropism of viral strains. It would be of value to 
compare multiple tissue IHC using a number of virus strains to determine the most suitable 
tissues for study in diagnostic cases. 
In this study, fetal serology did not prove efficacious with a frequency that would 
support its use in routine diagnostic settings. As mentioned in the paper, IgM IF A may prove 
more sensitive. A comparison of these techniques would be in order. Based on the findings 
in this work, fetal serology for PRRS will likely be relegated to that gray area it occupies in a 
number of other infectious conditions. 
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It must be noted that all the tested modalities depend on transplacental infection of the 
fetus by PRRSV. In the opinion of respected workers in this field, many abortions occur 
prior to transplacental infection of the fetus (Kelly Lager, personal communication), and 
therefor fetal examination will often prove futile. It has been reported as well that atypical 
strains of PRRSV can induce abortion in earlier pregnancy and that these fetuses are rarely or 
never viremic.9 If this is the case, then one must continue to investigate possible causes of 
PRRSV abortion that will coincide with clinical and pathologic findings. If the abortion is 
initiated by endocrine or cytokine factors affecting the sow's ability to maintain pregnancy, 
why do we see such a variety of fetal presentations within an affected litter? One would 
expect to see only a pile of uniformly affected dead fetuses in such a case. How does one 
fetus die and mummify, a second die shortly before abortion, and a third be weak at birth? 
What is the significance of fetal viremia? Alternatively, does the virus initiate an effect on 
the individual placenta, either directly or through paracrine cytokine effects, which has not 
been elucidated? Lesions in the placenta have not been abundant, although some 
ultrastructural changes have been described.16 Perhaps PRRS will take its place as one of 
those conditions in which the cellular and molecular workers will prove more successful than 
the light microscopists in the final definition of pathogenesis. 
Conclusion 
Porcine reproductive and respiratory syndrome continues to be an important 
economic disease of swine. Although much has been learned, in recent years the number of 
studies dealing with PRRSV has appeared to decrease in frequency, perhaps due to the 
increased interest in porcine circovirus related disease, and perhaps because the "easy miles" 
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have been covered. Further answers to the questions of pathogenesis may well require some 
well-designed and intricate studies of tissue and cell tropism and cytokine effects. 
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